CCL11

UniProt ID: P51671
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

CCL11 (also known as Eotaxin-1) is a secreted CC chemokine that functions as a potent and selective chemoattractant for eosinophils. It signals primarily through the G-protein-coupled receptor CCR3, inducing directed cell migration (chemotaxis), cytoskeletal rearrangement, calcium mobilization, and activation of downstream MAP kinase cascades (ERK2, p38). CCL11 is produced by fibroblasts, epithelial cells, endothelial cells, macrophages, and eosinophils themselves, and is induced by pro-inflammatory cytokines (TNF-alpha, IL-1alpha, IFN-gamma) and type-2 cytokines (IL-4, IL-13). Beyond eosinophil recruitment in allergic inflammation (asthma, atopic dermatitis), CCL11 also promotes endothelial cell proliferation and migration via CCR3 in the context of choroidal neovascularization, and has been implicated in neuroinflammation and cognitive decline via CCR3 signaling on microglia. The mature protein is 74 amino acids (after signal peptide cleavage), adopts a typical chemokine fold with a 3-stranded beta-sheet and overlying alpha-helix, and can exist in monomer-dimer equilibrium. It is O-glycosylated at Thr-94.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005615 extracellular space
IBA
GO_REF:0000033
ACCEPT
Summary: CCL11/Eotaxin is a secreted chemokine that functions in the extracellular space. UniProt annotates it as "Secreted" (PubMed:8597956). The IBA annotation is consistent with phylogenetic inference across the CC chemokine family.
Reason: CCL11 is a secreted protein that acts extracellularly to create chemotactic gradients. This is well-established and consistent with the signal peptide (residues 1-23) and its function as a soluble ligand for CCR3.
Supporting Evidence:
PMID:8597956
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.
GO:0008009 chemokine activity
IBA
GO_REF:0000033
ACCEPT
Summary: Chemokine activity is the core molecular function of CCL11. It acts as a chemoattractant primarily for eosinophils via CCR3 (PMID:8631813, PMID:10072545). The IBA annotation is phylogenetically sound across CC chemokines.
Reason: CCL11 is definitively a chemokine. Its primary molecular function is to act as a chemoattractant ligand, signaling through CCR3 to induce directed cell migration. This is its canonical and core function.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
GO:0070098 chemokine-mediated signaling pathway
IBA
GO_REF:0000033
ACCEPT
Summary: CCL11 is a chemokine ligand that initiates chemokine-mediated signaling through CCR3. This is directly supported by multiple studies showing CCL11 binding to CCR3 triggers downstream signaling cascades including MAP kinase activation (PMID:10706854) and calcium mobilization (PMID:10415069).
Reason: As a chemokine, CCL11 inherently participates in chemokine-mediated signaling pathways by binding and activating its receptor CCR3. This is a core function.
Supporting Evidence:
PMID:10706854
Eotaxin and other CC chemokines acting via CC chemokine receptor-3 (CCR3) are believed to play an integral role in the development of eosinophilic inflammation in asthma and allergic inflammatory diseases.
GO:0061844 antimicrobial humoral immune response mediated by antimicrobial peptide
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: This IBA annotation is propagated from the broader CC chemokine family. While some chemokines have direct antimicrobial peptide activity, CCL11/Eotaxin is primarily characterized as an eosinophil chemoattractant rather than a direct antimicrobial peptide. The evidence for direct antimicrobial activity of CCL11 specifically is limited.
Reason: While the IBA annotation reflects a phylogenetically-inferred function shared across CC chemokines, CCL11 is not primarily known for direct antimicrobial peptide activity. Its core function is eosinophil chemotaxis. Some CC chemokines do have antimicrobial properties, and this may apply to CCL11 as well, but it is not a core function.
GO:0048245 eosinophil chemotaxis
IBA
GO_REF:0000033
ACCEPT
Summary: Eosinophil chemotaxis is the canonical and best-characterized biological process of CCL11/Eotaxin. It was originally cloned as a specific eosinophil chemoattractant (PMID:8597956, PMID:8631813). The IBA annotation reinforces this across species.
Reason: This is arguably the single most defining function of CCL11. It was named "eotaxin" specifically for its eosinophil-selective chemotactic activity.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
GO:0030335 positive regulation of cell migration
IBA
GO_REF:0000033
ACCEPT
Summary: CCL11 promotes cell migration in multiple cell types. It induces eosinophil chemotaxis (PMID:10072545), endothelial cell migration (PMID:19525930), and FLS/monocyte migration (PMID:33846499). The IBA annotation is well-supported.
Reason: As a chemokine, positive regulation of cell migration is a core function of CCL11. This is supported by extensive experimental evidence across multiple cell types and contexts.
Supporting Evidence:
PMID:19525930
All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f).
GO:0006954 inflammatory response
IBA
GO_REF:0000033
ACCEPT
Summary: CCL11 is a pro-inflammatory chemokine that plays a central role in allergic inflammatory responses by recruiting eosinophils to sites of inflammation. This is well-established across multiple disease contexts including asthma and atopic dermatitis.
Reason: Involvement in inflammatory response is a core function of CCL11. It mediates eosinophil recruitment in type-2/allergic inflammation, which is its primary physiological role.
Supporting Evidence:
PMID:10708591
Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3.
GO:0048020 CCR chemokine receptor binding
IBA
GO_REF:0000033
ACCEPT
Summary: CCL11 binds CCR3 as its primary receptor (PMID:8631813). It can also interact with CCR5 and has controversial/partial activity at CCR2. The IBA annotation for CCR chemokine receptor binding is well-supported.
Reason: CCR chemokine receptor binding is a core molecular function of CCL11. It binds CCR3 with high affinity as its principal receptor. This is the parent term that encompasses the more specific CCR3 binding, which is also annotated.
Supporting Evidence:
PMID:9712872
The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy.
GO:0005125 cytokine activity
IEA
GO_REF:0000043
ACCEPT
Summary: CCL11 is classified as a cytokine (specifically a chemokine, which is a subclass of cytokines). The IEA annotation from UniProt keyword mapping is correct but less specific than the chemokine activity annotation.
Reason: Cytokine activity is a parent term of chemokine activity. While less specific, it is not incorrect. The more specific chemokine activity term is also present. Acceptable as a broader IEA annotation.
GO:0005576 extracellular region
IEA
GO_REF:0000120
ACCEPT
Summary: CCL11 is a secreted protein that localizes to the extracellular region. This IEA annotation is consistent with domain-based predictions and the established biology of chemokines.
Reason: Extracellular region is a broader parent of extracellular space. Both are correct for this secreted chemokine. The IEA annotation is consistent with multiple higher-evidence annotations.
GO:0005615 extracellular space
IEA
GO_REF:0000120
ACCEPT
Summary: Duplicate of the IBA annotation for the same term. CCL11 is secreted and acts in the extracellular space. This IEA annotation is redundant with the IBA annotation but not incorrect.
Reason: Correct localization for a secreted chemokine. Redundant with IBA but acceptable as independent evidence.
GO:0006935 chemotaxis
IEA
GO_REF:0000043
ACCEPT
Summary: CCL11 is a chemotactic factor. The IEA annotation from UniProt keyword mapping to chemotaxis is correct. More specific terms (eosinophil chemotaxis) are also annotated.
Reason: Chemotaxis is a core biological process for CCL11. This broader term is acceptable alongside the more specific eosinophil chemotaxis annotation.
GO:0006954 inflammatory response
IEA
GO_REF:0000043
ACCEPT
Summary: Duplicate of the IBA annotation for inflammatory response. CCL11 is clearly involved in inflammatory responses. The IEA from keyword mapping is redundant but correct.
Reason: Correct annotation, redundant with IBA annotation for the same term.
GO:0006955 immune response
IEA
GO_REF:0000002
ACCEPT
Summary: CCL11 participates in immune responses by recruiting eosinophils and other immune cells. The IEA annotation from InterPro domain mapping is correct but very broad.
Reason: Immune response is a broad parent term. While it is less informative than the more specific inflammatory response or eosinophil chemotaxis terms, it is not incorrect for this chemokine.
GO:0008009 chemokine activity
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for chemokine activity, redundant with the IBA and IDA annotations for the same term. Correct.
Reason: Correct core molecular function. Redundant with higher-evidence annotations.
GO:0005515 protein binding
IPI
PMID:18275857
Stromal cell-derived factors 1alpha and 1beta, inflammatory ...
MODIFY
Summary: This IPI annotation is from a study on dipeptidyl peptidase 8 (DPP8) substrates. The paper tested 27 chemokines for cleavage by DPP8, and CCL11 was among those surveyed but was NOT identified as a novel substrate of DPP8 (the novel substrates were IP10/CXCL10, ITAC/CXCL11, and SDF-1/CXCL12). The WITH column shows UniProtKB:P27487 (DPP4). This likely reflects a physical interaction detected by IntAct, but the term "protein binding" is uninformative.
Reason: Protein binding is uninformative per curation guidelines. CCL11 can be processed by DPP4 (CD26) via N-terminal truncation, which is a well-known regulatory mechanism for chemokines. A more informative annotation would capture this as a substrate relationship. However, the interaction with DPP4 is real and documented.
Proposed replacements: protein binding
Supporting Evidence:
PMID:18275857
N-terminal truncation of chemokines by proteases including dipeptidyl peptidase (DP) IV significantly alters their biological activity; generally ablating cognate G-protein coupled receptor engagement and often generating potent receptor antagonists.
GO:0005515 protein binding
IPI
PMID:21314817
Neuropeptide Y, B-type natriuretic peptide, substance P and ...
MODIFY
Summary: This IPI annotation from a study on fibroblast activation protein-alpha (FAP) substrates. The WITH column shows UniProtKB:P27487 (DPP4). The paper explicitly states that FAP showed negligible or no hydrolysis of chemokines that are readily hydrolysed by DPP4. This suggests the annotation reflects the CCL11-DPP4 interaction rather than CCL11-FAP interaction.
Reason: Protein binding is uninformative per curation guidelines. The interaction with DPP4 is the relevant binding interaction here.
Proposed replacements: protein binding
Supporting Evidence:
PMID:21314817
FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4.
GO:0005515 protein binding
IPI
PMID:23597562
Inhibition of tumor angiogenesis and growth by a small-molec...
MODIFY
Summary: This IPI annotation is from a study on a small-molecule FGF receptor blocker. The WITH column shows UniProtKB:P51677 (CCR3). This reflects the CCL11-CCR3 physical interaction. While the paper itself is about FGF receptor inhibition, the IntAct interaction data likely captures the well-known CCL11-CCR3 binding.
Reason: Protein binding is uninformative. The actual interaction is CCL11 binding to CCR3, which is already captured by the more specific CCR3 chemokine receptor binding annotation (GO:0031728). This protein binding annotation should be replaced with the more specific term.
Proposed replacements: CCR3 chemokine receptor binding
Supporting Evidence:
PMID:23597562
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
GO:0005515 protein binding
IPI
PMID:28381538
Chemokine interactome mapping enables tailored intervention ...
MODIFY
Summary: This IPI annotation is from the chemokine interactome mapping study by von Hundelshausen et al. (2017). The study systematically mapped chemokine-chemokine interactions using immunoligand blotting and surface plasmon resonance. CCL11 was found to interact with multiple chemokines including CCL5/RANTES, PF4/CXCL4, CXCL10, CXCL12, CCL27, and CCL28. These are functionally relevant heteromeric interactions that can modulate chemokine activity.
Reason: Protein binding is uninformative. The specific interactions documented in this study (chemokine-chemokine heterodimer formation) are biologically meaningful but "protein binding" does not capture this. A better term would reflect the chemokine-chemokine interaction specifically.
Proposed replacements: CCR chemokine receptor binding
Supporting Evidence:
PMID:28381538
Heterophilic interactions between chemokines in a given microenvironment may amplify, inhibit, or modulate their activity; however, a systematic evaluation of the chemokine interactome has not been performed.
GO:0002544 chronic inflammatory response
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara ortholog transfer (rat Ccl11). CCL11 is involved in chronic inflammatory conditions such as asthma and atopic dermatitis. The annotation is plausible but represents a more specific inflammatory context.
Reason: CCL11 is involved in chronic inflammatory conditions (asthma, atopic dermatitis, RA), but this is a downstream consequence of its chemotactic function rather than a distinct core function. Keeping as non-core.
GO:0002551 mast cell chemotaxis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (rat ortholog). While CCR3 is expressed on mast cells and CCL11 can theoretically attract mast cells via CCR3, the primary evidence for CCL11 chemotactic activity is for eosinophils. In the AMD study (PMID:19525930), despite eotaxin expression, mast cells were NOT recruited, suggesting this function may be context-dependent.
Reason: While theoretically possible given CCR3 expression on mast cells, the evidence for CCL11-mediated mast cell chemotaxis is limited. In the AMD context (PMID:19525930), mast cells were not recruited despite eotaxin abundance. Eosinophil chemotaxis is the primary chemotactic function.
Supporting Evidence:
PMID:19525930
despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV.
GO:0007015 actin filament organization
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 signaling through CCR3 induces cytoskeletal rearrangement including actin polymerization, as demonstrated in eosinophils (PMID:10072545) and endothelial cells (PMID:19525930). This is a downstream effect of chemokine signaling rather than a direct function of the ligand.
Reason: Actin filament organization occurs in responding cells as a consequence of CCR3 activation by CCL11, not as a direct biochemical function of the CCL11 protein itself. This is a downstream cellular response to the chemokine signal.
GO:0007611 learning or memory
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (mouse ortholog Ccl11, P48298). Recent reviews describe CCL11 as contributing to cognitive impairment by inhibiting neurogenesis, reducing synaptic density, and promoting neuronal cytotoxicity via CCR3 on microglia. However, this is a pleiotropic effect observed in aging contexts, not a core evolved function.
Reason: The link between CCL11 and learning/memory is based on aging studies in mice where elevated blood CCL11 impairs hippocampal neurogenesis and cognition. This is a pleiotropic pathological effect in aging rather than a core evolved function of the chemokine.
GO:0035962 response to interleukin-13
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by IL-13 (a type-2 cytokine) in various cell types. This annotation likely reflects that CCL11 gene expression responds to IL-13 signaling, which is well-established in the context of type-2 inflammation.
Reason: This describes the regulation of CCL11 expression rather than a function of the CCL11 protein. CCL11 production is induced by IL-13, but this is about gene regulation, not protein function. Keep as non-core contextual information.
GO:0045766 positive regulation of angiogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (mouse ortholog). CCL11 promotes angiogenesis through CCR3 on endothelial cells, as demonstrated in the AMD/choroidal neovascularization study (PMID:19525930). Eotaxins stimulated endothelial cell proliferation, actin polymerization, and migration. This is a well-supported non-core function.
Reason: While experimentally supported (PMID:19525930), positive regulation of angiogenesis is a secondary/pleiotropic function of CCL11 rather than its core evolved chemotactic function. It occurs in specific pathological contexts like AMD where CCR3 is expressed on neovascular endothelial cells.
Supporting Evidence:
PMID:19525930
each of the three eotaxins stimulated human CEC proliferation
GO:0048245 eosinophil chemotaxis
IEA
GO_REF:0000107
ACCEPT
Summary: IEA from Ensembl Compara (rat ortholog). Redundant with IBA and IDA annotations for the same term. Eosinophil chemotaxis is the core function of CCL11.
Reason: Correct core function. Redundant with higher-evidence annotations but independently derived from ortholog transfer.
GO:0050768 negative regulation of neurogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (mouse ortholog). CCL11 has been shown to inhibit neurogenesis in mouse aging studies. This is a pleiotropic effect linked to aging rather than a core function.
Reason: Negative regulation of neurogenesis is a secondary/aging-related effect of CCL11 observed in mouse studies, not a core evolved function of this chemokine.
GO:0070371 ERK1 and ERK2 cascade
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 activates ERK2 and p38 MAP kinases in eosinophils (PMID:10706854). This is a downstream signaling event triggered by CCR3 activation, not a direct function of CCL11 itself.
Reason: The ERK1/ERK2 cascade is activated downstream of CCR3 signaling upon CCL11 binding. While experimentally demonstrated, this describes a downstream signaling consequence in the responding cell, not a direct function of the secreted chemokine ligand. The annotation is on the gene product that triggers the cascade as a ligand, which is a somewhat indirect relationship.
Supporting Evidence:
PMID:10706854
Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38.
GO:0070670 response to interleukin-4
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by IL-4 signaling (via STAT6), which is well-established in the type-2 inflammation context. This annotation describes regulation of CCL11 gene expression rather than a function of the CCL11 protein.
Reason: This describes gene regulation (CCL11 expression is induced by IL-4) rather than a function of the CCL11 protein product. Keep as non-core contextual information.
GO:0060326 cell chemotaxis
IDA
PMID:33846499
Eotaxin-1/CCL11 is involved in cell migration in rheumatoid ...
ACCEPT
Summary: IDA annotation from PMID:33846499 (Wakabayashi et al., 2021). This study demonstrated that CCL11 induces migration of RA fibroblast-like synoviocytes (FLS) and THP-1 monocytes in transwell migration assays. CCL11-stimulated FLS migrated significantly more than unstimulated cells, and CCL11 siRNA knockdown reduced FLS migration.
Reason: Cell chemotaxis is a core function of CCL11 as a chemokine. This study provides direct experimental evidence that CCL11 induces directed cell migration in multiple cell types beyond eosinophils, including fibroblast-like synoviocytes and monocytes.
Supporting Evidence:
PMID:33846499
CCL11-stimulated cells migrated significantly more efficiently than unstimulated cells (mean ± SEM, number of cells per field; 35.8 ± 5.2 and 24.5 ± 4.6, respectively, p < 0.05, Fig. 5A)
GO:0070098 chemokine-mediated signaling pathway
IDA
PMID:19525930
CCR3 is a target for age-related macular degeneration diagno...
ACCEPT
Summary: IDA annotation from Takeda et al. (2009, Nature). The study demonstrated that CCL11 (eotaxin-1) activates CCR3-mediated signaling in choroidal endothelial cells, promoting proliferation, actin polymerization, Rac-1 activation, and migration. This is direct evidence of CCL11 initiating chemokine-mediated signaling.
Reason: Well-supported by experimental evidence in the Nature paper. CCL11 binding to CCR3 activates downstream signaling cascades in endothelial cells, constituting chemokine-mediated signaling.
Supporting Evidence:
PMID:19525930
Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules
GO:0050768 negative regulation of neurogenesis
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation transferred from mouse ortholog (P48298). CCL11 has been shown to inhibit hippocampal neurogenesis in aging mouse studies. This is a pleiotropic effect related to aging/neuroinflammation rather than a core function.
Reason: Based on sequence similarity to mouse Ccl11 which was experimentally shown to inhibit neurogenesis. This is a pleiotropic aging-related effect, not a core evolved function. Redundant with IEA annotation.
GO:0007611 learning or memory
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation transferred from mouse ortholog (P48298). CCL11 affects learning and memory in mouse aging studies. This is a pleiotropic neuroinflammatory effect. Redundant with IEA annotation.
Reason: Pleiotropic aging-related effect transferred from mouse ortholog studies. Not a core evolved function of this chemokine.
GO:0046983 protein dimerization activity
IDA
PMID:9712872
Solution structure of eotaxin, a chemokine that selectively ...
ACCEPT
Summary: IDA annotation from the NMR structural study by Crump et al. (1998). The study determined the solution structure of eotaxin and found it exists in equilibrium between monomer and dimer under a wide range of conditions. At pH <= 5 and low ionic strength, eotaxin was predominantly monomeric. This is a genuine biophysical property of the protein.
Reason: Protein dimerization is an experimentally demonstrated property of CCL11. Many CC chemokines form dimers, and this is likely biologically relevant for creating chemokine gradients and modulating activity.
Supporting Evidence:
PMID:9712872
The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions.
GO:0031728 CCR3 chemokine receptor binding
IDA
PMID:11425309
NMR solution structure and backbone dynamics of the CC chemo...
ACCEPT
Summary: IDA annotation from the eotaxin-3 structural study. Note that PMID:11425309 is actually about eotaxin-3 (CCL26), not eotaxin-1 (CCL11). However, CCL11 binding to CCR3 is very well established from multiple other studies (PMID:8631813, PMID:10072545). The reference may be incorrectly assigned but the annotation itself is correct.
Reason: CCR3 binding is the core molecular function of CCL11. While the specific reference (about eotaxin-3 structure) may not be the best citation for CCL11 specifically, the function is unambiguously correct and well-established from the original cloning papers (PMID:8631813).
Supporting Evidence:
PMID:9712872
The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy.
GO:0048018 receptor ligand activity
IDA
PMID:11425309
NMR solution structure and backbone dynamics of the CC chemo...
ACCEPT
Summary: IDA annotation. CCL11 is a receptor ligand (for CCR3). This is a fundamental molecular function description -- CCL11 acts as a ligand that activates a receptor (CCR3 GPCR). While the reference is about eotaxin-3, the function is correct for CCL11.
Reason: Receptor ligand activity is a core molecular function of CCL11. It acts as a signaling ligand for the CCR3 G-protein coupled receptor.
GO:0005576 extracellular region
IDA
PMID:20041150
Missense mutations in the MEFV gene are associated with fibr...
ACCEPT
Summary: IDA annotation with reference to PMID:20041150, a paper about MEFV gene mutations in fibromyalgia. This paper measured CCL11 levels in plasma, demonstrating it is present in the extracellular region (blood). The annotation is correct for CCL11 localization.
Reason: CCL11 is a secreted protein found in the extracellular region. The reference measured CCL11 in plasma, confirming its extracellular localization. While the paper is primarily about MEFV, the detection of CCL11 in plasma supports the annotation.
GO:0007010 cytoskeleton organization
IDA
PMID:10072545
Differential regulation of eosinophil chemokine signaling vi...
KEEP AS NON CORE
Summary: IDA annotation from Sabroe et al. (1999). The study showed that eotaxin induces leukocyte shape change mediated through rearrangements of the cellular cytoskeleton, essential for leukocyte migration. This is a downstream cellular response to CCL11/CCR3 signaling in responding cells.
Reason: Cytoskeleton organization in eosinophils is a downstream consequence of CCR3 activation by CCL11, not a direct function of the CCL11 protein. The ligand triggers cytoskeletal changes in the responding cell.
Supporting Evidence:
PMID:10072545
Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation.
GO:0008009 chemokine activity
IDA
PMID:10072545
Differential regulation of eosinophil chemokine signaling vi...
ACCEPT
Summary: IDA annotation from Sabroe et al. (1999). The study directly demonstrated that eotaxin acts as a chemokine by inducing rapid shape change and chemotactic responses in eosinophils via CCR3. This is direct experimental evidence for chemokine activity.
Reason: Core molecular function demonstrated by direct experimental evidence. Eotaxin was shown to be among the most potent CCR3-acting chemokines for eosinophil activation.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
GO:0008360 regulation of cell shape
IDA
PMID:10072545
Differential regulation of eosinophil chemokine signaling vi...
KEEP AS NON CORE
Summary: IDA annotation from Sabroe et al. (1999). CCL11 induces eosinophil shape change through cytoskeletal rearrangement. This is a downstream cellular response to CCR3 activation in responding cells.
Reason: Regulation of cell shape is a downstream consequence of CCR3 signaling in eosinophils. While experimentally demonstrated, it is not a core function of the CCL11 protein itself but rather a response in target cells.
Supporting Evidence:
PMID:10072545
Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell
GO:0048245 eosinophil chemotaxis
IDA
PMID:10072545
Differential regulation of eosinophil chemokine signaling vi...
ACCEPT
Summary: IDA annotation from Sabroe et al. (1999). Direct experimental demonstration that eotaxin induces eosinophil chemotaxis via CCR3. This is the core biological function of CCL11.
Reason: Core function of CCL11 directly demonstrated experimentally. Eotaxin is among the most potent eosinophil chemoattractants acting via CCR3.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
GO:0001938 positive regulation of endothelial cell proliferation
IDA
PMID:19525930
CCR3 is a target for age-related macular degeneration diagno...
KEEP AS NON CORE
Summary: IDA annotation from Takeda et al. (2009, Nature). The study showed that each of the three eotaxins (including CCL11) stimulated human choroidal endothelial cell (CEC) proliferation, and CCR3 neutralizing antibodies reduced CEC proliferation in vivo. This is a well-supported but non-core function in the context of choroidal neovascularization.
Reason: While experimentally well-supported in a high-impact publication, this function is specific to the pathological context of choroidal neovascularization in AMD, where CCR3 is aberrantly expressed on endothelial cells. It is not the core evolved function of CCL11.
Supporting Evidence:
PMID:19525930
each of the three eotaxins stimulated human CEC proliferation
GO:0030335 positive regulation of cell migration
IDA
PMID:19525930
CCR3 is a target for age-related macular degeneration diagno...
ACCEPT
Summary: IDA annotation from Takeda et al. (2009). CCL11 promoted human CEC migration in a dose-dependent fashion, and activated Rac-1, a GTPase critical for endothelial cell spreading and migration. This reinforces the IBA annotation.
Reason: Positive regulation of cell migration is a core function of CCL11 as a chemokine. This IDA provides additional experimental evidence in endothelial cells beyond the eosinophil context.
Supporting Evidence:
PMID:19525930
All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f).
GO:0030838 positive regulation of actin filament polymerization
IDA
PMID:19525930
CCR3 is a target for age-related macular degeneration diagno...
KEEP AS NON CORE
Summary: IDA annotation from Takeda et al. (2009). Stimulation of human CECs with eotaxins induced rapid polymerization of actin molecules. This is a downstream cellular response to CCR3 signaling in endothelial cells.
Reason: Actin polymerization is a downstream cellular response in target cells following CCR3 activation by CCL11. It is not a direct function of the CCL11 protein itself but rather a consequence of its signaling activity.
Supporting Evidence:
PMID:19525930
Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules
GO:0005576 extracellular region
TAS
Reactome:R-HSA-443986
ACCEPT
Summary: TAS annotation from Reactome pathway "Receptor ACKR2 binds most inflammatory CC chemokines". CCL11 is a secreted protein that binds to ACKR2 (a decoy chemokine receptor) in the extracellular region. This is consistent with its localization as a secreted chemokine.
Reason: Correct localization for a secreted chemokine, supported by Reactome pathway curation.
GO:0005576 extracellular region
TAS
Reactome:R-HSA-6793978
ACCEPT
Summary: TAS annotation from Reactome pathway "Expression of STAT6-upregulated extracellular proteins". CCL11 is a STAT6-induced secreted protein, consistent with its regulation by IL-4/IL-13 signaling and extracellular localization.
Reason: Correct localization. CCL11 is a STAT6-regulated secreted protein.
GO:0006468 protein phosphorylation
TAS
PMID:10706854
Eotaxin induces degranulation and chemotaxis of eosinophils ...
MODIFY
Summary: TAS annotation citing Kampen et al. (2000). The paper shows that eotaxin induces phosphorylation of ERK2 and p38 in eosinophils. However, CCL11 is NOT a kinase -- it is a secreted chemokine ligand. The phosphorylation events are downstream signaling consequences in responding cells following CCR3 activation. Annotating CCL11 with "protein phosphorylation" is misleading as it implies CCL11 catalyzes phosphorylation.
Reason: CCL11 is a secreted chemokine with no kinase activity. The paper demonstrates that eotaxin-induced CCR3 signaling triggers phosphorylation of ERK2 and p38 in eosinophils, but CCL11 does not directly catalyze phosphorylation. The annotation should be modified to reflect that CCL11 triggers signaling cascades in responding cells. A more appropriate annotation would capture the upstream signaling role.
Supporting Evidence:
PMID:10706854
Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38. Phosphorylation was detectable after 30 seconds, peaked at about 1 minute, and returned to baseline after 2 to 5 minutes.
GO:0006874 intracellular calcium ion homeostasis
TAS
PMID:10415069
Chemokine receptor expression and signaling in macaque and h...
MARK AS OVER ANNOTATED
Summary: TAS annotation from Klein et al. (1999). The study showed that CCR3 on neurons responds to its chemokine ligands (including eotaxin/CCL11) with increases in intracellular calcium. However, calcium mobilization is a downstream signaling event in CCR3-expressing cells, not a direct function of the CCL11 ligand itself. Additionally, the term "homeostasis" is misleading -- CCL11 triggers transient calcium flux rather than maintaining calcium homeostasis.
Reason: Intracellular calcium ion homeostasis is a downstream signaling event in CCR3-expressing cells after CCL11 binding. CCL11 triggers transient calcium mobilization but does not maintain calcium homeostasis. This represents an over-annotation where a downstream response in target cells is attributed to the signaling ligand.
Supporting Evidence:
PMID:10415069
Chemokine receptors were shown to respond to their appropriate chemokine ligands with increases in intracellular calcium that, in the case of neurons, required predepolarization with KCl.
GO:0006935 chemotaxis
TAS
PMID:10706854
Eotaxin induces degranulation and chemotaxis of eosinophils ...
ACCEPT
Summary: TAS annotation from Kampen et al. (2000). The study directly demonstrated eotaxin-induced eosinophil chemotaxis using Boyden microchambers and showed that MAP kinase inhibitors blocked this chemotaxis.
Reason: Chemotaxis is a core function of CCL11. This TAS annotation is well-supported by the referenced study and consistent with multiple other annotations.
Supporting Evidence:
PMID:10706854
We conclude that eotaxin induces a rapid concentration-dependent activation of ERK2 and p38 in eosinophils and that the activation of these MAP kinases is required for eotaxin-stimulated degranulation and directed locomotion.
GO:0006954 inflammatory response
TAS
PMID:10708591
Cell-type-dependent induction of eotaxin and CCR3 by ionizin...
ACCEPT
Summary: TAS annotation from Huber et al. (2000). The paper describes induction of eotaxin and CCR3 by ionizing radiation and discusses CCL11 in the context of eosinophilic inflammatory diseases.
Reason: Inflammatory response is a core process for CCL11. The paper directly discusses CCL11 in the context of eosinophilic inflammatory pathogenesis.
Supporting Evidence:
PMID:10708591
Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3.
GO:0007155 cell adhesion
TAS
PMID:10201960
Eotaxin activates T cells to chemotaxis and adhesion only if...
KEEP AS NON CORE
Summary: TAS annotation from Jinquan et al. (1999). The study showed that eotaxin, in combination with IL-2 and IL-4, enhances expression of adhesion molecules (ICAM-1, CD29, CD49a, CD49b) on T lymphocytes and promotes adhesion and aggregation. However, the adhesion effect required prior IL-2/IL-4 stimulation to induce CCR3 expression on T cells and is an indirect consequence of chemokine signaling.
Reason: Cell adhesion promotion by CCL11 is context-dependent (requires IL-2/IL-4 co-stimulation to induce CCR3 on T cells) and is a downstream consequence of CCR3 signaling rather than a direct adhesion function.
Supporting Evidence:
PMID:10201960
In combination with IL-2 and IL-4, eotaxin enhances the expression of adhesion molecules such as ICAM-1 and several integrins (CD29, CD49a, and CD49b) on T lymphocytes and thus promotes adhesion and aggregation of T lymphocytes.
GO:0007165 signal transduction
TAS
PMID:10706854
Eotaxin induces degranulation and chemotaxis of eosinophils ...
ACCEPT
Summary: TAS annotation from Kampen et al. (2000). The study demonstrated that eotaxin induces signal transduction through CCR3, activating ERK2 and p38 MAP kinases. Signal transduction is a very broad term; more specific terms are available.
Reason: While very broad, signal transduction is correct for CCL11 as a signaling ligand that activates receptor-mediated signaling cascades. More specific terms (chemokine-mediated signaling pathway) are also annotated.
GO:0009314 response to radiation
TAS
PMID:10708591
Cell-type-dependent induction of eotaxin and CCR3 by ionizin...
MARK AS OVER ANNOTATED
Summary: TAS annotation from Huber et al. (2000). The paper showed that CCL11 (eotaxin) expression is upregulated by ionizing radiation in human dermal fibroblasts. This describes the regulation of CCL11 gene expression in response to radiation, not a function of the CCL11 protein.
Reason: This annotation describes the induction of CCL11 gene expression by ionizing radiation, not a function of the CCL11 protein itself. The CCL11 protein does not sense or respond to radiation; rather, its expression is upregulated by radiation in certain cell types. This is an annotation about gene regulation inappropriately applied to the gene product.
Supporting Evidence:
PMID:10708591
the expression of eotaxin is upregulated upon treatment with ionizing radiation (IR) in human dermal fibroblasts
GO:0009615 response to virus
TAS
PMID:9558100
Dendritic cells express multiple chemokine receptors used as...
MARK AS OVER ANNOTATED
Summary: TAS annotation from Rubbert et al. (1998). The paper describes CCR3 as an HIV coreceptor on dendritic cells. CCR3 is identified as an eotaxin receptor on dendritic cells that may be used for HIV entry. However, this paper does not demonstrate a role for CCL11 in response to virus -- rather, it shows that the CCL11 receptor CCR3 can be exploited by HIV for cell entry. This is an over-annotation.
Reason: The cited paper describes CCR3 (the eotaxin receptor) as an HIV coreceptor on dendritic cells. This does not demonstrate that CCL11 protein itself participates in response to virus. The viral exploitation of CCR3 is a property of the receptor, not the chemokine ligand.
Supporting Evidence:
PMID:9558100
CCR3, the eotaxin receptor, initially identified on eosinophils, is expressed on DC and may be used as an entry coreceptor by certain dual-tropic strains.

Core Functions

CCL11 (Eotaxin-1) functions as a secreted CC chemokine that acts in the extracellular space as a potent and selective chemoattractant for eosinophils. This is its defining and canonical function. It was named "eotaxin" specifically for this eosinophil-selective chemotactic activity. CCL11 plays a central role in allergic/type-2 inflammatory responses by recruiting eosinophils to sites of inflammation, and is implicated in the pathogenesis of asthma, atopic dermatitis, eosinophilic esophagitis, and other eosinophilic inflammatory diseases.

Molecular Function:
chemokine activity
Cellular Locations:

CCL11 binds with high affinity to CCR3, a G-protein-coupled receptor expressed primarily on eosinophils, basophils, and certain other cell types. CCR3 binding is the molecular mechanism by which CCL11 exerts its chemotactic and signaling functions. Upon binding, CCR3 activates downstream signaling cascades including calcium mobilization, ERK2/p38 MAP kinase activation, and cytoskeletal rearrangement.

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.
  • Original cloning and functional characterization of human CCL11/eotaxin as a specific eosinophil chemoattractant.
Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.
  • Identified CCR3 as the specific receptor for eotaxin/CCL11.
Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.
  • Determined NMR solution structure of eotaxin showing typical chemokine fold.
  • Showed monomer-dimer equilibrium under a wide range of conditions.
Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
  • Demonstrated eotaxin and eotaxin-2 are the most potent CCR3-acting chemokines for eosinophil shape change.
  • Showed CCL11 induces cytoskeletal rearrangement and shape change in eosinophils via CCR3.
Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
  • Showed eotaxin can induce T cell chemotaxis and adhesion but only after IL-2/IL-4 induction of CCR3 expression.
Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS.
  • Demonstrated CCR3 on fetal neurons responds to chemokine ligands with calcium mobilization.
Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases.
  • Showed eotaxin induces concentration-dependent phosphorylation of ERK2 and p38 in eosinophils.
  • Demonstrated MAP kinase activation is required for eotaxin-induced degranulation and chemotaxis.
Cell-type-dependent induction of eotaxin and CCR3 by ionizing radiation.
  • Showed eotaxin expression is upregulated by ionizing radiation in dermal fibroblasts.
NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3.
  • Structural study of eotaxin-3 (CCL26), which shares CCR3 as receptor with CCL11.
Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8.
  • Surveyed chemokines for DPP8 cleavage; CCL11 was not a novel DPP8 substrate.
CCR3 is a target for age-related macular degeneration diagnosis and therapy.
  • Demonstrated CCL11/eotaxins promote endothelial cell proliferation, actin polymerization, and migration via CCR3.
  • Showed CCR3 targeting inhibits choroidal neovascularization.
  • Genetic ablation of Ccl11 reduced CNV in mice.
Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels.
  • Measured CCL11 levels in plasma (demonstrates extracellular localization).
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α.
  • FAP showed negligible hydrolysis of chemokines including CCL11.
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
  • IntAct interaction data for CCL11-CCR3 binding derived from this study.
Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.
  • Systematic mapping of chemokine-chemokine interactions including CCL11 heteromeric interactions.
Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis.
  • Demonstrated CCL11 induces migration of RA FLS and THP-1 monocytes.
  • Showed CCL11 siRNA knockdown reduces FLS migration.
  • CCL11 levels elevated in RA serum and synovial fluid.
Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry.
  • Described CCR3 as HIV coreceptor on dendritic cells.
Reactome:R-HSA-443986
Receptor ACKR2 binds most inflammatory CC chemokines
Reactome:R-HSA-6793978
Expression of STAT6-upregulated extracellular proteins

📚 Additional Documentation

Deep Research Falcon

(CCL11-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-03-06T03:10:19.457115'
end_time: '2026-03-06T03:20:07.995637'
duration_seconds: 588.54
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: CCL11
gene_symbol: CCL11
uniprot_accession: P51671
protein_description: 'RecName: Full=Eotaxin; AltName: Full=C-C motif chemokine 11;
AltName: Full=Eosinophil chemotactic protein; AltName: Full=Small-inducible cytokine
A11; Flags: Precursor;'
gene_info: Name=CCL11; Synonyms=SCYA11;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the intercrine beta (chemokine CC) family.
protein_domains: Chemokine_b/g/d. (IPR039809); Chemokine_CC_CS. (IPR000827); Chemokine_IL8-like_dom.
(IPR001811); Interleukin_8-like_sf. (IPR036048); IL8 (PF00048)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 29


Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: P51671
  • Protein Description: RecName: Full=Eotaxin; AltName: Full=C-C motif chemokine 11; AltName: Full=Eosinophil chemotactic protein; AltName: Full=Small-inducible cytokine A11; Flags: Precursor;
  • Gene Information: Name=CCL11; Synonyms=SCYA11;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the intercrine beta (chemokine CC) family.
  • Key Domains: Chemokine_b/g/d. (IPR039809); Chemokine_CC_CS. (IPR000827); Chemokine_IL8-like_dom. (IPR001811); Interleukin_8-like_sf. (IPR036048); IL8 (PF00048)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "CCL11" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'CCL11' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene CCL11 (gene ID: CCL11, UniProt: P51671) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Research report: Human CCL11 (Eotaxin-1) functional annotation (UniProt P51671)

1) Verification of gene/protein identity (mandatory)

The UniProt accession P51671 corresponds to human CCL11, commonly called eotaxin‑1 and historically described as an eosinophil chemotactic protein; recent reviews continue to use these exact names and position it within the CC chemokine family (i.e., C‑C motif ligand 11). (wang2024spotlightonproinflammatory pages 6-7, wang2025emergingrolesof pages 4-5)

Functionally, the dominant, high‑affinity receptor is CCR3, which is repeatedly described as the principal receptor mediating canonical eotaxin‑1 biology (eosinophil recruitment/activation) and is consistent with CCL11 being a secreted chemokine ligand rather than an enzyme or transporter. (wang2025emergingrolesof pages 4-5, xie2024immunologicaspectsof pages 9-10)

2) Key concepts and definitions (current understanding)

2.1 What CCL11 is

CCL11 is a chemokine ligand that forms gradients in tissues and is best known for selective recruitment of eosinophils in type‑2/allergic inflammation. (wang2025emergingrolesof pages 4-5, wang2025emergingrolesof pages 2-4)

2.2 Canonical receptor axis (CCL11 → CCR3)

CCR3 is described as the main/high‑affinity receptor for CCL11 and as a G‑protein‑coupled receptor whose signaling is associated with intracellular calcium mobilization, supporting chemotaxis and activation in CCR3+ immune cells. (wang2025emergingrolesof pages 4-5)

In asthma-focused synthesis, CCR3 is selectively activated by eotaxin‑1 (CCL11) (as well as eotaxin‑2/CCL24 and eotaxin‑3/CCL26), and CCR3 activation—together with endothelial adhesion molecules—facilitates eosinophil recruitment from blood into lung tissues. (xie2024immunologicaspectsof pages 9-10)

2.3 Noncanonical/secondary receptor interactions

A recent focused review summarizes additional functional interactions: CCL11 can act as a CCR5 agonist (and can induce CCR5 internalization in monocytes/macrophages) and has complex/controversial CCR2 activity (reported as partial agonist in some settings or as a natural antagonist in others). (wang2025emergingrolesof pages 4-5)

2.4 Cellular sources and inducibility

Across recent reviews, CCL11 production is attributed to many cell types, including eosinophils, T and B cells, fibroblasts, epithelial cells, endothelial cells, macrophages, and in CNS discussions also microglia. (wang2024spotlightonproinflammatory pages 6-7, wang2025emergingrolesof pages 2-4)

Type‑2 cytokines are repeatedly cited as upstream inducers; for example, Th2 cytokines IL‑4, IL‑10, and IL‑13 induce CCL11 production in a 2024 review of chemokines in cognitive impairment. (wang2024spotlightonproinflammatory pages 6-7)

3) Primary molecular function, pathways, and localization

3.1 Primary function: chemotaxis (not enzymatic catalysis)

CCL11 is not an enzyme; its primary biochemical role is chemokine signaling as a soluble ligand that binds chemokine receptors and orchestrates directed cell migration and related activation programs.

3.2 Extracellular localization and tissue-to-tissue trafficking

CCL11 is treated in recent literature as an extracellular, secreted mediator that can function in blood and tissues and—importantly for CNS indications—can be transported from blood to brain via the blood–brain barrier (BBB). (wang2024spotlightonproinflammatory pages 6-7)

3.3 Allergic airway disease: eosinophil recruitment and extravasation

A 2024 asthma immunology review describes a mechanistic module in which eotaxin‑1 (CCL11) selectively activates CCR3 and, together with endothelial adhesion molecule expression—especially VCAM‑1 and ICAM‑1—supports recruitment/extravasation of eosinophils from blood into lung mucosa and interstitium. (xie2024immunologicaspectsof pages 9-10)

A more mechanistic, multi-context synthesis highlights airway‑relevant producers and inductive pathways: bronchial epithelial cells can be induced via IL‑4/STAT6, and airway smooth muscle cells via IL‑17A‑driven MAPK pathways (p38/JNK/ERK); eosinophils themselves can be major sources, supporting an autocrine chemotactic loop. (wang2025emergingrolesof pages 2-4)

3.4 Neuroinflammation/cognitive impairment: CCR3–NOX‑1–ROS axis in microglia

A 2024 Frontiers in Immunology review frames CCL11 as an aging/accelerated aging immune marker and summarizes mechanistic links to cognition: CCL11 can contribute to cognitive impairment by inhibiting neurogenesis, reducing synaptic density, and promoting neuronal cytotoxicity. (wang2024spotlightonproinflammatory pages 6-7, wang2024spotlightonproinflammatory pages 7-8)

Mechanistically, the same review proposes a microglial pathway in which CCL11 binding to CCR3 on microglia upregulates NOX‑1, increases microglial ROS, and drives inflammation-associated neuronal injury/death. (wang2024spotlightonproinflammatory pages 6-7)

3.5 Angiogenesis and remodeling (CCR3 on endothelial cells; PI3K/Akt and MAPKs)

A recent mechanistic synthesis describes evidence that CCL11 can act on CCR3+ endothelial cells to promote angiogenic responses and can signal through pathways including PI3K/Akt and ERK/p38, and can upregulate matrix remodeling enzymes (e.g., MMP-2/3) in a CCR3-dependent fashion. (wang2025emergingrolesof pages 7-9)

4) Recent developments (prioritizing 2023–2024)

4.1 2023: Recombinant CCL11 can induce pro-oxidant DNA damage responses and senescence programs in human lung fibroblasts

Lavandoski et al. (Frontiers in Immunology; published Oct 2023; https://doi.org/10.3389/fimmu.2023.1243537) tested recombinant human CCL11 (rhCCL11) in MRC‑5 human lung fibroblasts.

Key findings include:
- High‑dose rhCCL11 (500 ng/10^5 cells/mL) induced ROS overproduction within 60 minutes and persisting up to 4 hours (p<0.05). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
- rhCCL11 increased DNA damage response markers at 2 hours, with increased γH2AX (% positive p<0.0001; MFI p=0.005) and phospho‑TP53 (% positive p<0.0001; MFI p=0.0352), resolving by 24 hours. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
- A 24‑hour rhCCL11 exposure increased SA‑β‑gal senescence readout (percentage p=0.0481; MFI p=0.0229) and reduced proliferation marker Ki‑67 (p=0.0192). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
- rhCCL11 also promoted a pro-inflammatory senescence-associated secretory phenotype (SASP), increasing CCL11 secretion (p<0.0001) and increasing IL‑6 (p=0.0005) and IL‑8 (p=0.0008). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)

These data extend CCL11 functional annotation beyond chemotaxis by supporting direct, receptor-mediated (or receptor-associated) cellular stress programs in structural lung cells relevant to chronic airway disease biology. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)

Visual evidence from the primary paper: cropped panels for ROS kinetics and DNA-damage marker flow cytometry are available. (lavandoski2023eotaxin1ccl11promotescellular media 88940820, lavandoski2023eotaxin1ccl11promotescellular media ba4c996b)

4.2 2024: CCL11 in neuro-immune mechanisms of cognitive impairment

Wang et al. (Frontiers in Immunology; published Jul 2024; https://doi.org/10.3389/fimmu.2024.1421076) provides a 2024 review synthesis emphasizing that CCL11 can cross the BBB and engage CCR3 on CNS cells, and highlights microglial oxidative mechanisms (NOX‑1 → ROS) as a plausible route to neurotoxicity. (wang2024spotlightonproinflammatory pages 6-7)

4.3 2024: CCL11/CCR3 in asthma immune translation

Xie et al. (Frontiers in Immunology; published Oct 2024; https://doi.org/10.3389/fimmu.2024.1478624) integrates CCL11 into the type‑2 asthma effector framework in which CCR3 activation by eotaxins enables eosinophil recruitment, coordinated with IL‑4/IL‑13-driven endothelial adhesion molecule priming (VCAM‑1/ICAM‑1). (xie2024immunologicaspectsof pages 9-10)

5) Current applications and real-world implementations

5.1 Clinical biomarker use case: traumatic brain injury (TBI)

Negrin et al. (Journal of Clinical Medicine; published Jul 2024; https://doi.org/10.3390/jcm13144218) evaluated serum eotaxin (CCL11) in a matched polytrauma cohort.

Reported performance characteristics include:
- ROC AUC = 0.718 for admission eotaxin level identifying TBI (limited clinical utility). (negrin2024differencesineotaxin pages 1-2, negrin2024differencesineotaxin pages 9-10)
- A cutoff of 154 pg/mL yielded sensitivity 0.707 and specificity 0.683. (negrin2024differencesineotaxin pages 1-2)
- Odds of prevalent TBI increased 10.5% per 20 pg/mL increase in admission eotaxin. (negrin2024differencesineotaxin pages 1-2)

This is a concrete example of CCL11 deployment as an acute-care biomarker candidate, with quantified performance. (negrin2024differencesineotaxin pages 1-2)

5.2 Clinical trials/registries measuring eotaxin/CCL11

ClinicalTrials.gov includes observational implementations where eotaxin/CCL11 is an analyte:

  • NCT06211244 (Sponsor: Tungs’ Taichung Metroharbour Hospital) “Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients” (Status: Completed; Start 2024-05-02, Completion 2024-12-31; Enrollment 291). Primary outcome: serum eotaxin biomarker analysis by ELISA; includes secondary inflammatory/oxidative injury markers (IL‑6, MCP‑1, 8‑isoprostane) and cardiac injury marker hs‑troponin I. (NCT06211244 chunk 1)

  • NCT03521882 (Royal Devon and Exeter NHS Foundation Trust) “Timed Interval Measurement of Eotaxin in Stroke Study” (Status: Completed; Start 2017-05-22; Completion 2019-05-30). Primary outcome: plasma eotaxin concentration tracked across 0–7 days after stroke-like presentations to define kinetics/feasibility for larger studies. (NCT03521882 chunk 1)

These registry entries reflect real-world implementation of CCL11 measurement as a clinical research biomarker rather than a therapeutic product. (NCT06211244 chunk 1, NCT03521882 chunk 1)

6) Expert opinions and authoritative synthesis (what reviews converge on)

Across recent reviews, there is strong consensus that:
1) CCL11–CCR3 is the core axis for eosinophil recruitment/activation in type‑2 inflammation, with CCL11 being one of the eotaxins that selectively activate CCR3. (xie2024immunologicaspectsof pages 9-10, wang2025emergingrolesof pages 4-5)
2) CCL11 has pleiotropic context-dependent biology beyond eosinophil chemotaxis (e.g., tissue remodeling/angiogenesis, CNS effects), and may act via CCR3 on non-hematopoietic cells and through additional chemokine receptors in certain contexts (CCR5; CCR2 disputed). (wang2025emergingrolesof pages 7-9, wang2025emergingrolesof pages 4-5)
3) In CNS contexts, CCL11 is increasingly discussed as part of inflammatory aging frameworks and neuroinflammation, including oxidative stress mechanisms in microglia. (wang2024spotlightonproinflammatory pages 6-7)

7) Key statistics/data points (recent studies)

  • TBI biomarker performance (2024): AUC 0.718; cutoff 154 pg/mL; sensitivity 0.707; specificity 0.683; +10.5% odds of TBI per 20 pg/mL eotaxin increase. (negrin2024differencesineotaxin pages 1-2, negrin2024differencesineotaxin pages 9-10)
  • rhCCL11 mechanistic cell biology (2023): ROS induction within 60 min (p<0.05); γH2AX and p‑TP53 induction at 2h (p<0.0001 for % positive; MFI p=0.005 and p=0.0352); SA‑β‑gal increase at 24h (p=0.0481; MFI p=0.0229); Ki‑67 reduction (p=0.0192); increased IL‑6 (p=0.0005) and IL‑8 (p=0.0008). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)

8) Summary: functional annotation statement (for databases)

CCL11 (eotaxin‑1) is a secreted CC chemokine ligand whose canonical function is CCR3‑dependent chemotaxis and activation of eosinophils (and other CCR3+ type‑2 immune cells), central to type‑2/allergic inflammation including asthma, where eosinophil extravasation is coordinated with endothelial adhesion pathways. (xie2024immunologicaspectsof pages 9-10, wang2025emergingrolesof pages 4-5)

Beyond leukocyte trafficking, recent primary and review evidence supports roles in (i) neuroinflammation and cognitive impairment via BBB trafficking and microglial CCR3–NOX‑1–ROS signaling, and (ii) tissue remodeling/angiogenesis via CCR3+ endothelial signaling (e.g., PI3K/Akt, ERK/p38) and matrix remodeling programs. (wang2024spotlightonproinflammatory pages 6-7, wang2025emergingrolesof pages 7-9)

Finally, recombinant CCL11 can directly induce pro-oxidant DNA damage signaling and senescence-associated phenotypes in human lung fibroblasts, suggesting a mechanistic link between chronic inflammatory chemokines and structural-cell aging programs relevant to airway disease. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7, lavandoski2023eotaxin1ccl11promotescellular media 88940820)


Functional Context Key Receptor & Signaling Producing Cells / Inducers Target Cells & Outcomes Key Evidence / Statistics Recent Source
Allergic Airway Disease CCR3 (High affinity, primary); CCR5 (agonist); CCR2 (antagonist/partial). Signals via $Ca^{2+}$ mobilization (wang2025emergingrolesof pages 4-5). Eosinophils (autocrine), Epithelium (IL-4/STAT6), Smooth Muscle (IL-17A/MAPK) (wang2025emergingrolesof pages 2-4). Eosinophils, Basophils, Th2 cells. Drives chemotaxis, activation, and Th2 polarization (wang2025emergingrolesof pages 5-7). Elevated CCR3/CCL11 correlates with asthma severity. CCR3 mediates extravasation via VCAM-1 interaction (xie2024immunologicaspectsof pages 9-10). Wang et al. 2025 (wang2025emergingrolesof pages 1-2)
Xie et al. 2024 (xie2024immunologicaspectsof pages 9-10)
Neuroinflammation & Cognitive Decline CCR3 (Microglia). Upregulates NOX-1, increasing ROS production (wang2024spotlightonproinflammatory pages 6-7). Neurons, Astrocytes, Microglia. Induced by IL-4, IL-13, aging factors (wang2024spotlightonproinflammatory pages 6-7). Microglia, Neurons. Inhibits neurogenesis, reduces synaptic density, promotes cytotoxicity (wang2024spotlightonproinflammatory pages 6-7). Anti-CCL11 Ab improved motor outcomes in PD mice (wang2024spotlightonproinflammatory pages 6-7). Plasma from aged mice impairs memory in young mice (wang2024spotlightonproinflammatory pages 7-8). Wang et al. 2024 (wang2024spotlightonproinflammatory pages 6-7)
Angiogenesis & Tissue Remodeling CCR3 (Endothelial). Signals via PI3K/Akt, ERK/p38 MAPK (wang2025emergingrolesof pages 7-9). Endothelial cells, Fibroblasts (wang2025emergingrolesof pages 2-4). Endothelial cells. Promotes chemotaxis, vascularization, and ECM remodeling (MMP-2/3) (wang2025emergingrolesof pages 7-9). Recombinant CCL11 directly induces angiogenic responses in vivo and promotes HUVEC vascularization (wang2025emergingrolesof pages 7-9). Wang et al. 2025 (wang2025emergingrolesof pages 7-9)
Cellular Senescence CCR3. Activates DNA Damage Response (p-p53, $\gamma$H2AX) via ROS (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). Lung Fibroblasts (Autocrine loop) (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). Fibroblasts. Induces senescence (SA-$\beta$-gal), reduces proliferation (Ki-67), SASP secretion (IL-6/8) (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). rhCCL11 (500 ng/mL) increased ROS (<60 min) and $\gamma$H2AX ($p<0.0001$, 2h); increased SA-$\beta$-gal at 24h ($p=0.048$) (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). Lavandoski et al. 2023 (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
TBI Biomarker N/A (Systemic detection). Brain tissue (sole source after TBI) (negrin2024differencesineotaxin pages 1-2). Systemic circulation (Diagnostic marker). Cutoff 154 pg/mL for TBI diagnosis: Sens 0.707, Spec 0.683, AUC 0.718. Odds +10.5% per 20 pg/mL increase (negrin2024differencesineotaxin pages 9-10). Negrin et al. 2024 (negrin2024differencesineotaxin pages 1-2, negrin2024differencesineotaxin pages 9-10)
Clinical Trials N/A Patient Serum/Plasma levels. Hemodialysis; Stroke patients. NCT06211244 (2024): Serum Eotaxin/Myocardiac injury. NCT03521882: Plasma Eotaxin kinetics in stroke (NCT06211244 chunk 1, NCT03521882 chunk 1). ClinicalTrials.gov (NCT06211244 chunk 1, NCT03521882 chunk 1)

Table: A summary of human CCL11 functions, mechanisms, and clinical relevance based on recent literature, highlighting its dual roles in allergic inflammation and aging-associated pathologies.

References (URLs and publication dates)

  • Lavandoski P. et al. Eotaxin‑1/CCL11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology. Oct 2023. https://doi.org/10.3389/fimmu.2023.1243537 (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
  • Wang C. et al. Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment. Frontiers in Immunology. Jul 2024. https://doi.org/10.3389/fimmu.2024.1421076 (wang2024spotlightonproinflammatory pages 6-7)
  • Xie C. et al. Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation. Frontiers in Immunology. Oct 2024. https://doi.org/10.3389/fimmu.2024.1478624 (xie2024immunologicaspectsof pages 9-10)
  • Negrin L.L. et al. Differences in Eotaxin Serum Levels between Polytraumatized Patients with and without Concomitant Traumatic Brain Injury—A Matched Pair Analysis. Journal of Clinical Medicine. Jul 2024. https://doi.org/10.3390/jcm13144218 (negrin2024differencesineotaxin pages 1-2)
  • ClinicalTrials.gov. NCT06211244. “Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients.” Start 2024‑05‑02; Completed; Completion 2024‑12‑31. https://clinicaltrials.gov/study/NCT06211244 (NCT06211244 chunk 1)
  • ClinicalTrials.gov. NCT03521882. “Timed Interval Measurement of Eotaxin in Stroke Study.” Completed; last update posted 2020‑11‑06. https://clinicaltrials.gov/study/NCT03521882 (NCT03521882 chunk 1)

References

  1. (wang2024spotlightonproinflammatory pages 6-7): Chenxu Wang, Jiayi Wang, Zhichao Zhu, Jialing Hu, and Yong Lin. Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment. Frontiers in Immunology, Jul 2024. URL: https://doi.org/10.3389/fimmu.2024.1421076, doi:10.3389/fimmu.2024.1421076. This article has 26 citations and is from a peer-reviewed journal.

  2. (wang2025emergingrolesof pages 4-5): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.

  3. (xie2024immunologicaspectsof pages 9-10): Cong Xie, Jingyan Yang, Aman Gul, Yifan Li, Rui Zhang, Maimaititusun Yalikun, Xiaotong Lv, Yuhan Lin, Qingli Luo, and Huijuan Gao. Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation. Frontiers in Immunology, Oct 2024. URL: https://doi.org/10.3389/fimmu.2024.1478624, doi:10.3389/fimmu.2024.1478624. This article has 42 citations and is from a peer-reviewed journal.

  4. (wang2025emergingrolesof pages 2-4): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.

  5. (wang2024spotlightonproinflammatory pages 7-8): Chenxu Wang, Jiayi Wang, Zhichao Zhu, Jialing Hu, and Yong Lin. Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment. Frontiers in Immunology, Jul 2024. URL: https://doi.org/10.3389/fimmu.2024.1421076, doi:10.3389/fimmu.2024.1421076. This article has 26 citations and is from a peer-reviewed journal.

  6. (wang2025emergingrolesof pages 7-9): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.

  7. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7): Patrícia Lavandoski, Vinícius Pierdoná, Rafael Moura Maurmann, Lucas Kich Grun, Fatima T. C. R. Guma, and Florencia María Barbé-Tuana. Eotaxin-1/ccl11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1243537, doi:10.3389/fimmu.2023.1243537. This article has 29 citations and is from a peer-reviewed journal.

  8. (lavandoski2023eotaxin1ccl11promotescellular media 88940820): Patrícia Lavandoski, Vinícius Pierdoná, Rafael Moura Maurmann, Lucas Kich Grun, Fatima T. C. R. Guma, and Florencia María Barbé-Tuana. Eotaxin-1/ccl11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1243537, doi:10.3389/fimmu.2023.1243537. This article has 29 citations and is from a peer-reviewed journal.

  9. (lavandoski2023eotaxin1ccl11promotescellular media ba4c996b): Patrícia Lavandoski, Vinícius Pierdoná, Rafael Moura Maurmann, Lucas Kich Grun, Fatima T. C. R. Guma, and Florencia María Barbé-Tuana. Eotaxin-1/ccl11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1243537, doi:10.3389/fimmu.2023.1243537. This article has 29 citations and is from a peer-reviewed journal.

  10. (negrin2024differencesineotaxin pages 1-2): Lukas L. Negrin, Robin Ristl, Gregor Wollner, and Stefan Hajdu. Differences in eotaxin serum levels between polytraumatized patients with and without concomitant traumatic brain injury—a matched pair analysis. Journal of Clinical Medicine, 13:4218, Jul 2024. URL: https://doi.org/10.3390/jcm13144218, doi:10.3390/jcm13144218. This article has 2 citations.

  11. (negrin2024differencesineotaxin pages 9-10): Lukas L. Negrin, Robin Ristl, Gregor Wollner, and Stefan Hajdu. Differences in eotaxin serum levels between polytraumatized patients with and without concomitant traumatic brain injury—a matched pair analysis. Journal of Clinical Medicine, 13:4218, Jul 2024. URL: https://doi.org/10.3390/jcm13144218, doi:10.3390/jcm13144218. This article has 2 citations.

  12. (NCT06211244 chunk 1): Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients. Tungs' Taichung Metroharbour Hospital. 2024. ClinicalTrials.gov Identifier: NCT06211244

  13. (NCT03521882 chunk 1): Timed Interval Measurement of Eotaxin in Stroke Study. Royal Devon and Exeter NHS Foundation Trust. 2017. ClinicalTrials.gov Identifier: NCT03521882

  14. (wang2025emergingrolesof pages 5-7): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.

  15. (wang2025emergingrolesof pages 1-2): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.

Citations

  1. wang2025emergingrolesof pages 4-5
  2. xie2024immunologicaspectsof pages 9-10
  3. wang2024spotlightonproinflammatory pages 6-7
  4. wang2025emergingrolesof pages 2-4
  5. wang2025emergingrolesof pages 7-9
  6. negrin2024differencesineotaxin pages 1-2
  7. wang2025emergingrolesof pages 5-7
  8. wang2025emergingrolesof pages 1-2
  9. wang2024spotlightonproinflammatory pages 7-8
  10. negrin2024differencesineotaxin pages 9-10
  11. Wang et al. 2025
  12. Xie et al. 2024
  13. Wang et al. 2024
  14. Lavandoski et al. 2023
  15. Negrin et al. 2024
  16. ClinicalTrials.gov
  17. https://doi.org/10.3389/fimmu.2023.1243537
  18. https://doi.org/10.3389/fimmu.2024.1421076
  19. https://doi.org/10.3389/fimmu.2024.1478624
  20. https://doi.org/10.3390/jcm13144218
  21. https://doi.org/10.3390/ijms26104662
  22. https://clinicaltrials.gov
  23. https://clinicaltrials.gov/study/NCT06211244
  24. https://clinicaltrials.gov/study/NCT03521882
  25. https://doi.org/10.3389/fimmu.2024.1421076,
  26. https://doi.org/10.3390/ijms26104662,
  27. https://doi.org/10.3389/fimmu.2024.1478624,
  28. https://doi.org/10.3389/fimmu.2023.1243537,
  29. https://doi.org/10.3390/jcm13144218,

📄 View Raw YAML

id: P51671
gene_symbol: CCL11
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  CCL11 (also known as Eotaxin-1) is a secreted CC chemokine that functions as a potent
  and selective chemoattractant for eosinophils. It signals primarily through the
  G-protein-coupled receptor CCR3, inducing directed cell migration (chemotaxis),
  cytoskeletal rearrangement, calcium mobilization, and activation of downstream
  MAP kinase cascades (ERK2, p38). CCL11 is produced by fibroblasts, epithelial cells,
  endothelial cells, macrophages, and eosinophils themselves, and is induced by
  pro-inflammatory cytokines (TNF-alpha, IL-1alpha, IFN-gamma) and type-2 cytokines
  (IL-4, IL-13). Beyond eosinophil recruitment in allergic inflammation (asthma, atopic
  dermatitis), CCL11 also promotes endothelial cell proliferation and migration via
  CCR3 in the context of choroidal neovascularization, and has been implicated in
  neuroinflammation and cognitive decline via CCR3 signaling on microglia. The mature
  protein is 74 amino acids (after signal peptide cleavage), adopts a typical chemokine
  fold with a 3-stranded beta-sheet and overlying alpha-helix, and can exist in
  monomer-dimer equilibrium. It is O-glycosylated at Thr-94.
existing_annotations:
  - term:
      id: GO:0005615
      label: extracellular space
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        CCL11/Eotaxin is a secreted chemokine that functions in the extracellular
        space. UniProt annotates it as "Secreted" (PubMed:8597956). The IBA annotation
        is consistent with phylogenetic inference across the CC chemokine family.
      action: ACCEPT
      reason: >-
        CCL11 is a secreted protein that acts extracellularly to create chemotactic
        gradients. This is well-established and consistent with the signal peptide
        (residues 1-23) and its function as a soluble ligand for CCR3.
      supported_by:
        - reference_id: PMID:8597956
          supporting_text: "Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia."

  - term:
      id: GO:0008009
      label: chemokine activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        Chemokine activity is the core molecular function of CCL11. It acts as a
        chemoattractant primarily for eosinophils via CCR3 (PMID:8631813, PMID:10072545).
        The IBA annotation is phylogenetically sound across CC chemokines.
      action: ACCEPT
      reason: >-
        CCL11 is definitively a chemokine. Its primary molecular function is to act
        as a chemoattractant ligand, signaling through CCR3 to induce directed cell
        migration. This is its canonical and core function.
      supported_by:
        - reference_id: PMID:10072545
          supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."

  - term:
      id: GO:0070098
      label: chemokine-mediated signaling pathway
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        CCL11 is a chemokine ligand that initiates chemokine-mediated signaling through
        CCR3. This is directly supported by multiple studies showing CCL11 binding to
        CCR3 triggers downstream signaling cascades including MAP kinase activation
        (PMID:10706854) and calcium mobilization (PMID:10415069).
      action: ACCEPT
      reason: >-
        As a chemokine, CCL11 inherently participates in chemokine-mediated signaling
        pathways by binding and activating its receptor CCR3. This is a core function.
      supported_by:
        - reference_id: PMID:10706854
          supporting_text: "Eotaxin and other CC chemokines acting via CC chemokine receptor-3 (CCR3) are believed to play an integral role in the development of eosinophilic inflammation in asthma and allergic inflammatory diseases."

  - term:
      id: GO:0061844
      label: antimicrobial humoral immune response mediated by antimicrobial peptide
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        This IBA annotation is propagated from the broader CC chemokine family. While
        some chemokines have direct antimicrobial peptide activity, CCL11/Eotaxin is
        primarily characterized as an eosinophil chemoattractant rather than a direct
        antimicrobial peptide. The evidence for direct antimicrobial activity of CCL11
        specifically is limited.
      action: KEEP_AS_NON_CORE
      reason: >-
        While the IBA annotation reflects a phylogenetically-inferred function shared
        across CC chemokines, CCL11 is not primarily known for direct antimicrobial
        peptide activity. Its core function is eosinophil chemotaxis. Some CC chemokines
        do have antimicrobial properties, and this may apply to CCL11 as well, but it
        is not a core function.

  - term:
      id: GO:0048245
      label: eosinophil chemotaxis
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        Eosinophil chemotaxis is the canonical and best-characterized biological
        process of CCL11/Eotaxin. It was originally cloned as a specific eosinophil
        chemoattractant (PMID:8597956, PMID:8631813). The IBA annotation reinforces
        this across species.
      action: ACCEPT
      reason: >-
        This is arguably the single most defining function of CCL11. It was named
        "eotaxin" specifically for its eosinophil-selective chemotactic activity.
      supported_by:
        - reference_id: PMID:10072545
          supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."

  - term:
      id: GO:0030335
      label: positive regulation of cell migration
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        CCL11 promotes cell migration in multiple cell types. It induces eosinophil
        chemotaxis (PMID:10072545), endothelial cell migration (PMID:19525930), and
        FLS/monocyte migration (PMID:33846499). The IBA annotation is well-supported.
      action: ACCEPT
      reason: >-
        As a chemokine, positive regulation of cell migration is a core function of
        CCL11. This is supported by extensive experimental evidence across multiple
        cell types and contexts.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f)."

  - term:
      id: GO:0006954
      label: inflammatory response
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        CCL11 is a pro-inflammatory chemokine that plays a central role in allergic
        inflammatory responses by recruiting eosinophils to sites of inflammation.
        This is well-established across multiple disease contexts including asthma
        and atopic dermatitis.
      action: ACCEPT
      reason: >-
        Involvement in inflammatory response is a core function of CCL11. It mediates
        eosinophil recruitment in type-2/allergic inflammation, which is its primary
        physiological role.
      supported_by:
        - reference_id: PMID:10708591
          supporting_text: "Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3."

  - term:
      id: GO:0048020
      label: CCR chemokine receptor binding
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        CCL11 binds CCR3 as its primary receptor (PMID:8631813). It can also interact
        with CCR5 and has controversial/partial activity at CCR2. The IBA annotation
        for CCR chemokine receptor binding is well-supported.
      action: ACCEPT
      reason: >-
        CCR chemokine receptor binding is a core molecular function of CCL11. It binds
        CCR3 with high affinity as its principal receptor. This is the parent term that
        encompasses the more specific CCR3 binding, which is also annotated.
      supported_by:
        - reference_id: PMID:9712872
          supporting_text: "The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy."

  - term:
      id: GO:0005125
      label: cytokine activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        CCL11 is classified as a cytokine (specifically a chemokine, which is a
        subclass of cytokines). The IEA annotation from UniProt keyword mapping is
        correct but less specific than the chemokine activity annotation.
      action: ACCEPT
      reason: >-
        Cytokine activity is a parent term of chemokine activity. While less specific,
        it is not incorrect. The more specific chemokine activity term is also present.
        Acceptable as a broader IEA annotation.

  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        CCL11 is a secreted protein that localizes to the extracellular region.
        This IEA annotation is consistent with domain-based predictions and the
        established biology of chemokines.
      action: ACCEPT
      reason: >-
        Extracellular region is a broader parent of extracellular space. Both are
        correct for this secreted chemokine. The IEA annotation is consistent with
        multiple higher-evidence annotations.

  - term:
      id: GO:0005615
      label: extracellular space
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        Duplicate of the IBA annotation for the same term. CCL11 is secreted and
        acts in the extracellular space. This IEA annotation is redundant with
        the IBA annotation but not incorrect.
      action: ACCEPT
      reason: >-
        Correct localization for a secreted chemokine. Redundant with IBA but
        acceptable as independent evidence.

  - term:
      id: GO:0006935
      label: chemotaxis
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        CCL11 is a chemotactic factor. The IEA annotation from UniProt keyword
        mapping to chemotaxis is correct. More specific terms (eosinophil chemotaxis)
        are also annotated.
      action: ACCEPT
      reason: >-
        Chemotaxis is a core biological process for CCL11. This broader term is
        acceptable alongside the more specific eosinophil chemotaxis annotation.

  - term:
      id: GO:0006954
      label: inflammatory response
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        Duplicate of the IBA annotation for inflammatory response. CCL11 is clearly
        involved in inflammatory responses. The IEA from keyword mapping is redundant
        but correct.
      action: ACCEPT
      reason: >-
        Correct annotation, redundant with IBA annotation for the same term.

  - term:
      id: GO:0006955
      label: immune response
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: >-
        CCL11 participates in immune responses by recruiting eosinophils and other
        immune cells. The IEA annotation from InterPro domain mapping is correct
        but very broad.
      action: ACCEPT
      reason: >-
        Immune response is a broad parent term. While it is less informative than
        the more specific inflammatory response or eosinophil chemotaxis terms,
        it is not incorrect for this chemokine.

  - term:
      id: GO:0008009
      label: chemokine activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        IEA annotation for chemokine activity, redundant with the IBA and IDA
        annotations for the same term. Correct.
      action: ACCEPT
      reason: >-
        Correct core molecular function. Redundant with higher-evidence annotations.

  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:18275857
    review:
      summary: >-
        This IPI annotation is from a study on dipeptidyl peptidase 8 (DPP8) substrates.
        The paper tested 27 chemokines for cleavage by DPP8, and CCL11 was among those
        surveyed but was NOT identified as a novel substrate of DPP8 (the novel substrates
        were IP10/CXCL10, ITAC/CXCL11, and SDF-1/CXCL12). The WITH column shows
        UniProtKB:P27487 (DPP4). This likely reflects a physical interaction detected
        by IntAct, but the term "protein binding" is uninformative.
      action: MODIFY
      reason: >-
        Protein binding is uninformative per curation guidelines. CCL11 can be
        processed by DPP4 (CD26) via N-terminal truncation, which is a well-known
        regulatory mechanism for chemokines. A more informative annotation would
        capture this as a substrate relationship. However, the interaction with DPP4
        is real and documented.
      proposed_replacement_terms:
        - id: GO:0005515
          label: protein binding
      additional_reference_ids:
        - PMID:18275857
      supported_by:
        - reference_id: PMID:18275857
          supporting_text: "N-terminal truncation of chemokines by proteases including dipeptidyl peptidase (DP) IV significantly alters their biological activity; generally ablating cognate G-protein coupled receptor engagement and often generating potent receptor antagonists."

  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21314817
    review:
      summary: >-
        This IPI annotation from a study on fibroblast activation protein-alpha (FAP)
        substrates. The WITH column shows UniProtKB:P27487 (DPP4). The paper explicitly
        states that FAP showed negligible or no hydrolysis of chemokines that are
        readily hydrolysed by DPP4. This suggests the annotation reflects the
        CCL11-DPP4 interaction rather than CCL11-FAP interaction.
      action: MODIFY
      reason: >-
        Protein binding is uninformative per curation guidelines. The interaction
        with DPP4 is the relevant binding interaction here.
      proposed_replacement_terms:
        - id: GO:0005515
          label: protein binding
      supported_by:
        - reference_id: PMID:21314817
          supporting_text: "FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4."

  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:23597562
    review:
      summary: >-
        This IPI annotation is from a study on a small-molecule FGF receptor blocker.
        The WITH column shows UniProtKB:P51677 (CCR3). This reflects the CCL11-CCR3
        physical interaction. While the paper itself is about FGF receptor inhibition,
        the IntAct interaction data likely captures the well-known CCL11-CCR3 binding.
      action: MODIFY
      reason: >-
        Protein binding is uninformative. The actual interaction is CCL11 binding to
        CCR3, which is already captured by the more specific CCR3 chemokine receptor
        binding annotation (GO:0031728). This protein binding annotation should be
        replaced with the more specific term.
      proposed_replacement_terms:
        - id: GO:0031728
          label: CCR3 chemokine receptor binding
      supported_by:
        - reference_id: PMID:23597562
          supporting_text: "Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties."

  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:28381538
    review:
      summary: >-
        This IPI annotation is from the chemokine interactome mapping study by von
        Hundelshausen et al. (2017). The study systematically mapped chemokine-chemokine
        interactions using immunoligand blotting and surface plasmon resonance. CCL11
        was found to interact with multiple chemokines including CCL5/RANTES, PF4/CXCL4,
        CXCL10, CXCL12, CCL27, and CCL28. These are functionally relevant
        heteromeric interactions that can modulate chemokine activity.
      action: MODIFY
      reason: >-
        Protein binding is uninformative. The specific interactions documented in this
        study (chemokine-chemokine heterodimer formation) are biologically meaningful
        but "protein binding" does not capture this. A better term would reflect
        the chemokine-chemokine interaction specifically.
      proposed_replacement_terms:
        - id: GO:0048020
          label: CCR chemokine receptor binding
      supported_by:
        - reference_id: PMID:28381538
          supporting_text: "Heterophilic interactions between chemokines in a given microenvironment may amplify, inhibit, or modulate their activity; however, a systematic evaluation of the chemokine interactome has not been performed."

  - term:
      id: GO:0002544
      label: chronic inflammatory response
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara ortholog transfer (rat Ccl11). CCL11 is involved
        in chronic inflammatory conditions such as asthma and atopic dermatitis.
        The annotation is plausible but represents a more specific inflammatory
        context.
      action: KEEP_AS_NON_CORE
      reason: >-
        CCL11 is involved in chronic inflammatory conditions (asthma, atopic dermatitis,
        RA), but this is a downstream consequence of its chemotactic function rather
        than a distinct core function. Keeping as non-core.

  - term:
      id: GO:0002551
      label: mast cell chemotaxis
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (rat ortholog). While CCR3 is expressed on mast
        cells and CCL11 can theoretically attract mast cells via CCR3, the primary
        evidence for CCL11 chemotactic activity is for eosinophils. In the AMD study
        (PMID:19525930), despite eotaxin expression, mast cells were NOT recruited,
        suggesting this function may be context-dependent.
      action: KEEP_AS_NON_CORE
      reason: >-
        While theoretically possible given CCR3 expression on mast cells, the evidence
        for CCL11-mediated mast cell chemotaxis is limited. In the AMD context
        (PMID:19525930), mast cells were not recruited despite eotaxin abundance.
        Eosinophil chemotaxis is the primary chemotactic function.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV."

  - term:
      id: GO:0007015
      label: actin filament organization
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (rat ortholog). CCL11 signaling through CCR3 induces
        cytoskeletal rearrangement including actin polymerization, as demonstrated
        in eosinophils (PMID:10072545) and endothelial cells (PMID:19525930). This is
        a downstream effect of chemokine signaling rather than a direct function of
        the ligand.
      action: KEEP_AS_NON_CORE
      reason: >-
        Actin filament organization occurs in responding cells as a consequence of
        CCR3 activation by CCL11, not as a direct biochemical function of the CCL11
        protein itself. This is a downstream cellular response to the chemokine signal.

  - term:
      id: GO:0007611
      label: learning or memory
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (mouse ortholog Ccl11, P48298). Recent reviews
        describe CCL11 as contributing to cognitive impairment by inhibiting
        neurogenesis, reducing synaptic density, and promoting neuronal cytotoxicity
        via CCR3 on microglia. However, this is a pleiotropic effect observed in
        aging contexts, not a core evolved function.
      action: KEEP_AS_NON_CORE
      reason: >-
        The link between CCL11 and learning/memory is based on aging studies in mice
        where elevated blood CCL11 impairs hippocampal neurogenesis and cognition.
        This is a pleiotropic pathological effect in aging rather than a core
        evolved function of the chemokine.

  - term:
      id: GO:0035962
      label: response to interleukin-13
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by
        IL-13 (a type-2 cytokine) in various cell types. This annotation likely
        reflects that CCL11 gene expression responds to IL-13 signaling, which is
        well-established in the context of type-2 inflammation.
      action: KEEP_AS_NON_CORE
      reason: >-
        This describes the regulation of CCL11 expression rather than a function
        of the CCL11 protein. CCL11 production is induced by IL-13, but this is
        about gene regulation, not protein function. Keep as non-core contextual
        information.

  - term:
      id: GO:0045766
      label: positive regulation of angiogenesis
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (mouse ortholog). CCL11 promotes angiogenesis through
        CCR3 on endothelial cells, as demonstrated in the AMD/choroidal neovascularization
        study (PMID:19525930). Eotaxins stimulated endothelial cell proliferation,
        actin polymerization, and migration. This is a well-supported non-core function.
      action: KEEP_AS_NON_CORE
      reason: >-
        While experimentally supported (PMID:19525930), positive regulation of
        angiogenesis is a secondary/pleiotropic function of CCL11 rather than its
        core evolved chemotactic function. It occurs in specific pathological contexts
        like AMD where CCR3 is expressed on neovascular endothelial cells.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "each of the three eotaxins stimulated human CEC proliferation"

  - term:
      id: GO:0048245
      label: eosinophil chemotaxis
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (rat ortholog). Redundant with IBA and IDA
        annotations for the same term. Eosinophil chemotaxis is the core function
        of CCL11.
      action: ACCEPT
      reason: >-
        Correct core function. Redundant with higher-evidence annotations but
        independently derived from ortholog transfer.

  - term:
      id: GO:0050768
      label: negative regulation of neurogenesis
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (mouse ortholog). CCL11 has been shown to inhibit
        neurogenesis in mouse aging studies. This is a pleiotropic effect linked to
        aging rather than a core function.
      action: KEEP_AS_NON_CORE
      reason: >-
        Negative regulation of neurogenesis is a secondary/aging-related effect of
        CCL11 observed in mouse studies, not a core evolved function of this chemokine.

  - term:
      id: GO:0070371
      label: ERK1 and ERK2 cascade
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (rat ortholog). CCL11 activates ERK2 and p38 MAP
        kinases in eosinophils (PMID:10706854). This is a downstream signaling event
        triggered by CCR3 activation, not a direct function of CCL11 itself.
      action: KEEP_AS_NON_CORE
      reason: >-
        The ERK1/ERK2 cascade is activated downstream of CCR3 signaling upon CCL11
        binding. While experimentally demonstrated, this describes a downstream
        signaling consequence in the responding cell, not a direct function of the
        secreted chemokine ligand. The annotation is on the gene product that triggers
        the cascade as a ligand, which is a somewhat indirect relationship.
      supported_by:
        - reference_id: PMID:10706854
          supporting_text: "Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38."

  - term:
      id: GO:0070670
      label: response to interleukin-4
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by IL-4
        signaling (via STAT6), which is well-established in the type-2 inflammation
        context. This annotation describes regulation of CCL11 gene expression rather
        than a function of the CCL11 protein.
      action: KEEP_AS_NON_CORE
      reason: >-
        This describes gene regulation (CCL11 expression is induced by IL-4) rather
        than a function of the CCL11 protein product. Keep as non-core contextual
        information.

  - term:
      id: GO:0060326
      label: cell chemotaxis
    evidence_type: IDA
    original_reference_id: PMID:33846499
    review:
      summary: >-
        IDA annotation from PMID:33846499 (Wakabayashi et al., 2021). This study
        demonstrated that CCL11 induces migration of RA fibroblast-like synoviocytes
        (FLS) and THP-1 monocytes in transwell migration assays. CCL11-stimulated
        FLS migrated significantly more than unstimulated cells, and CCL11 siRNA
        knockdown reduced FLS migration.
      action: ACCEPT
      reason: >-
        Cell chemotaxis is a core function of CCL11 as a chemokine. This study
        provides direct experimental evidence that CCL11 induces directed cell
        migration in multiple cell types beyond eosinophils, including fibroblast-like
        synoviocytes and monocytes.
      supported_by:
        - reference_id: PMID:33846499
          supporting_text: "CCL11-stimulated cells migrated significantly more efficiently than unstimulated cells (mean ± SEM, number of cells per field; 35.8 ± 5.2 and 24.5 ± 4.6, respectively, p < 0.05, Fig. 5A)"

  - term:
      id: GO:0070098
      label: chemokine-mediated signaling pathway
    evidence_type: IDA
    original_reference_id: PMID:19525930
    review:
      summary: >-
        IDA annotation from Takeda et al. (2009, Nature). The study demonstrated
        that CCL11 (eotaxin-1) activates CCR3-mediated signaling in choroidal
        endothelial cells, promoting proliferation, actin polymerization, Rac-1
        activation, and migration. This is direct evidence of CCL11 initiating
        chemokine-mediated signaling.
      action: ACCEPT
      reason: >-
        Well-supported by experimental evidence in the Nature paper. CCL11 binding
        to CCR3 activates downstream signaling cascades in endothelial cells,
        constituting chemokine-mediated signaling.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules"

  - term:
      id: GO:0050768
      label: negative regulation of neurogenesis
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred from mouse ortholog (P48298). CCL11 has been
        shown to inhibit hippocampal neurogenesis in aging mouse studies. This is
        a pleiotropic effect related to aging/neuroinflammation rather than a core
        function.
      action: KEEP_AS_NON_CORE
      reason: >-
        Based on sequence similarity to mouse Ccl11 which was experimentally shown
        to inhibit neurogenesis. This is a pleiotropic aging-related effect, not a
        core evolved function. Redundant with IEA annotation.

  - term:
      id: GO:0007611
      label: learning or memory
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred from mouse ortholog (P48298). CCL11 affects
        learning and memory in mouse aging studies. This is a pleiotropic
        neuroinflammatory effect. Redundant with IEA annotation.
      action: KEEP_AS_NON_CORE
      reason: >-
        Pleiotropic aging-related effect transferred from mouse ortholog studies.
        Not a core evolved function of this chemokine.

  - term:
      id: GO:0046983
      label: protein dimerization activity
    evidence_type: IDA
    original_reference_id: PMID:9712872
    review:
      summary: >-
        IDA annotation from the NMR structural study by Crump et al. (1998). The
        study determined the solution structure of eotaxin and found it exists in
        equilibrium between monomer and dimer under a wide range of conditions. At
        pH <= 5 and low ionic strength, eotaxin was predominantly monomeric. This
        is a genuine biophysical property of the protein.
      action: ACCEPT
      reason: >-
        Protein dimerization is an experimentally demonstrated property of CCL11.
        Many CC chemokines form dimers, and this is likely biologically relevant
        for creating chemokine gradients and modulating activity.
      supported_by:
        - reference_id: PMID:9712872
          supporting_text: "The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions."

  - term:
      id: GO:0031728
      label: CCR3 chemokine receptor binding
    evidence_type: IDA
    original_reference_id: PMID:11425309
    review:
      summary: >-
        IDA annotation from the eotaxin-3 structural study. Note that PMID:11425309
        is actually about eotaxin-3 (CCL26), not eotaxin-1 (CCL11). However, CCL11
        binding to CCR3 is very well established from multiple other studies
        (PMID:8631813, PMID:10072545). The reference may be incorrectly assigned
        but the annotation itself is correct.
      action: ACCEPT
      reason: >-
        CCR3 binding is the core molecular function of CCL11. While the specific
        reference (about eotaxin-3 structure) may not be the best citation for
        CCL11 specifically, the function is unambiguously correct and well-established
        from the original cloning papers (PMID:8631813).
      supported_by:
        - reference_id: PMID:9712872
          supporting_text: "The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy."

  - term:
      id: GO:0048018
      label: receptor ligand activity
    evidence_type: IDA
    original_reference_id: PMID:11425309
    review:
      summary: >-
        IDA annotation. CCL11 is a receptor ligand (for CCR3). This is a fundamental
        molecular function description -- CCL11 acts as a ligand that activates a
        receptor (CCR3 GPCR). While the reference is about eotaxin-3, the function
        is correct for CCL11.
      action: ACCEPT
      reason: >-
        Receptor ligand activity is a core molecular function of CCL11. It acts
        as a signaling ligand for the CCR3 G-protein coupled receptor.

  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: IDA
    original_reference_id: PMID:20041150
    review:
      summary: >-
        IDA annotation with reference to PMID:20041150, a paper about MEFV gene
        mutations in fibromyalgia. This paper measured CCL11 levels in plasma,
        demonstrating it is present in the extracellular region (blood). The
        annotation is correct for CCL11 localization.
      action: ACCEPT
      reason: >-
        CCL11 is a secreted protein found in the extracellular region. The reference
        measured CCL11 in plasma, confirming its extracellular localization. While
        the paper is primarily about MEFV, the detection of CCL11 in plasma supports
        the annotation.

  - term:
      id: GO:0007010
      label: cytoskeleton organization
    evidence_type: IDA
    original_reference_id: PMID:10072545
    review:
      summary: >-
        IDA annotation from Sabroe et al. (1999). The study showed that eotaxin
        induces leukocyte shape change mediated through rearrangements of the
        cellular cytoskeleton, essential for leukocyte migration. This is a
        downstream cellular response to CCL11/CCR3 signaling in responding cells.
      action: KEEP_AS_NON_CORE
      reason: >-
        Cytoskeleton organization in eosinophils is a downstream consequence of
        CCR3 activation by CCL11, not a direct function of the CCL11 protein.
        The ligand triggers cytoskeletal changes in the responding cell.
      supported_by:
        - reference_id: PMID:10072545
          supporting_text: "Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation."

  - term:
      id: GO:0008009
      label: chemokine activity
    evidence_type: IDA
    original_reference_id: PMID:10072545
    review:
      summary: >-
        IDA annotation from Sabroe et al. (1999). The study directly demonstrated
        that eotaxin acts as a chemokine by inducing rapid shape change and
        chemotactic responses in eosinophils via CCR3. This is direct experimental
        evidence for chemokine activity.
      action: ACCEPT
      reason: >-
        Core molecular function demonstrated by direct experimental evidence.
        Eotaxin was shown to be among the most potent CCR3-acting chemokines
        for eosinophil activation.
      supported_by:
        - reference_id: PMID:10072545
          supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."

  - term:
      id: GO:0008360
      label: regulation of cell shape
    evidence_type: IDA
    original_reference_id: PMID:10072545
    review:
      summary: >-
        IDA annotation from Sabroe et al. (1999). CCL11 induces eosinophil shape
        change through cytoskeletal rearrangement. This is a downstream cellular
        response to CCR3 activation in responding cells.
      action: KEEP_AS_NON_CORE
      reason: >-
        Regulation of cell shape is a downstream consequence of CCR3 signaling
        in eosinophils. While experimentally demonstrated, it is not a core
        function of the CCL11 protein itself but rather a response in target cells.
      supported_by:
        - reference_id: PMID:10072545
          supporting_text: "Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell"

  - term:
      id: GO:0048245
      label: eosinophil chemotaxis
    evidence_type: IDA
    original_reference_id: PMID:10072545
    review:
      summary: >-
        IDA annotation from Sabroe et al. (1999). Direct experimental demonstration
        that eotaxin induces eosinophil chemotaxis via CCR3. This is the core
        biological function of CCL11.
      action: ACCEPT
      reason: >-
        Core function of CCL11 directly demonstrated experimentally. Eotaxin
        is among the most potent eosinophil chemoattractants acting via CCR3.
      supported_by:
        - reference_id: PMID:10072545
          supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."

  - term:
      id: GO:0001938
      label: positive regulation of endothelial cell proliferation
    evidence_type: IDA
    original_reference_id: PMID:19525930
    review:
      summary: >-
        IDA annotation from Takeda et al. (2009, Nature). The study showed that
        each of the three eotaxins (including CCL11) stimulated human choroidal
        endothelial cell (CEC) proliferation, and CCR3 neutralizing antibodies
        reduced CEC proliferation in vivo. This is a well-supported but non-core
        function in the context of choroidal neovascularization.
      action: KEEP_AS_NON_CORE
      reason: >-
        While experimentally well-supported in a high-impact publication, this
        function is specific to the pathological context of choroidal neovascularization
        in AMD, where CCR3 is aberrantly expressed on endothelial cells. It is not
        the core evolved function of CCL11.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "each of the three eotaxins stimulated human CEC proliferation"

  - term:
      id: GO:0030335
      label: positive regulation of cell migration
    evidence_type: IDA
    original_reference_id: PMID:19525930
    review:
      summary: >-
        IDA annotation from Takeda et al. (2009). CCL11 promoted human CEC migration
        in a dose-dependent fashion, and activated Rac-1, a GTPase critical for
        endothelial cell spreading and migration. This reinforces the IBA annotation.
      action: ACCEPT
      reason: >-
        Positive regulation of cell migration is a core function of CCL11 as a
        chemokine. This IDA provides additional experimental evidence in endothelial
        cells beyond the eosinophil context.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f)."

  - term:
      id: GO:0030838
      label: positive regulation of actin filament polymerization
    evidence_type: IDA
    original_reference_id: PMID:19525930
    review:
      summary: >-
        IDA annotation from Takeda et al. (2009). Stimulation of human CECs with
        eotaxins induced rapid polymerization of actin molecules. This is a
        downstream cellular response to CCR3 signaling in endothelial cells.
      action: KEEP_AS_NON_CORE
      reason: >-
        Actin polymerization is a downstream cellular response in target cells
        following CCR3 activation by CCL11. It is not a direct function of the
        CCL11 protein itself but rather a consequence of its signaling activity.
      supported_by:
        - reference_id: PMID:19525930
          supporting_text: "Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules"

  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-443986
    review:
      summary: >-
        TAS annotation from Reactome pathway "Receptor ACKR2 binds most inflammatory
        CC chemokines". CCL11 is a secreted protein that binds to ACKR2 (a decoy
        chemokine receptor) in the extracellular region. This is consistent with
        its localization as a secreted chemokine.
      action: ACCEPT
      reason: >-
        Correct localization for a secreted chemokine, supported by Reactome pathway
        curation.

  - term:
      id: GO:0005576
      label: extracellular region
    evidence_type: TAS
    original_reference_id: Reactome:R-HSA-6793978
    review:
      summary: >-
        TAS annotation from Reactome pathway "Expression of STAT6-upregulated
        extracellular proteins". CCL11 is a STAT6-induced secreted protein, consistent
        with its regulation by IL-4/IL-13 signaling and extracellular localization.
      action: ACCEPT
      reason: >-
        Correct localization. CCL11 is a STAT6-regulated secreted protein.

  - term:
      id: GO:0006468
      label: protein phosphorylation
    evidence_type: TAS
    original_reference_id: PMID:10706854
    review:
      summary: >-
        TAS annotation citing Kampen et al. (2000). The paper shows that eotaxin
        induces phosphorylation of ERK2 and p38 in eosinophils. However, CCL11 is
        NOT a kinase -- it is a secreted chemokine ligand. The phosphorylation events
        are downstream signaling consequences in responding cells following CCR3
        activation. Annotating CCL11 with "protein phosphorylation" is misleading
        as it implies CCL11 catalyzes phosphorylation.
      action: MODIFY
      reason: >-
        CCL11 is a secreted chemokine with no kinase activity. The paper demonstrates
        that eotaxin-induced CCR3 signaling triggers phosphorylation of ERK2 and p38
        in eosinophils, but CCL11 does not directly catalyze phosphorylation. The
        annotation should be modified to reflect that CCL11 triggers signaling
        cascades in responding cells. A more appropriate annotation would capture the
        upstream signaling role.
      proposed_replacement_terms:
        - id: GO:0070098
          label: chemokine-mediated signaling pathway
      supported_by:
        - reference_id: PMID:10706854
          supporting_text: "Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38. Phosphorylation was detectable after 30 seconds, peaked at about 1 minute, and returned to baseline after 2 to 5 minutes."

  - term:
      id: GO:0006874
      label: intracellular calcium ion homeostasis
    evidence_type: TAS
    original_reference_id: PMID:10415069
    review:
      summary: >-
        TAS annotation from Klein et al. (1999). The study showed that CCR3 on
        neurons responds to its chemokine ligands (including eotaxin/CCL11) with
        increases in intracellular calcium. However, calcium mobilization is a
        downstream signaling event in CCR3-expressing cells, not a direct function
        of the CCL11 ligand itself. Additionally, the term "homeostasis" is
        misleading -- CCL11 triggers transient calcium flux rather than maintaining
        calcium homeostasis.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Intracellular calcium ion homeostasis is a downstream signaling event in
        CCR3-expressing cells after CCL11 binding. CCL11 triggers transient calcium
        mobilization but does not maintain calcium homeostasis. This represents an
        over-annotation where a downstream response in target cells is attributed
        to the signaling ligand.
      supported_by:
        - reference_id: PMID:10415069
          supporting_text: "Chemokine receptors were shown to respond to their appropriate chemokine ligands with increases in intracellular calcium that, in the case of neurons, required predepolarization with KCl."

  - term:
      id: GO:0006935
      label: chemotaxis
    evidence_type: TAS
    original_reference_id: PMID:10706854
    review:
      summary: >-
        TAS annotation from Kampen et al. (2000). The study directly demonstrated
        eotaxin-induced eosinophil chemotaxis using Boyden microchambers and showed
        that MAP kinase inhibitors blocked this chemotaxis.
      action: ACCEPT
      reason: >-
        Chemotaxis is a core function of CCL11. This TAS annotation is well-supported
        by the referenced study and consistent with multiple other annotations.
      supported_by:
        - reference_id: PMID:10706854
          supporting_text: "We conclude that eotaxin induces a rapid concentration-dependent activation of ERK2 and p38 in eosinophils and that the activation of these MAP kinases is required for eotaxin-stimulated degranulation and directed locomotion."

  - term:
      id: GO:0006954
      label: inflammatory response
    evidence_type: TAS
    original_reference_id: PMID:10708591
    review:
      summary: >-
        TAS annotation from Huber et al. (2000). The paper describes induction of
        eotaxin and CCR3 by ionizing radiation and discusses CCL11 in the context
        of eosinophilic inflammatory diseases.
      action: ACCEPT
      reason: >-
        Inflammatory response is a core process for CCL11. The paper directly
        discusses CCL11 in the context of eosinophilic inflammatory pathogenesis.
      supported_by:
        - reference_id: PMID:10708591
          supporting_text: "Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3."

  - term:
      id: GO:0007155
      label: cell adhesion
    evidence_type: TAS
    original_reference_id: PMID:10201960
    review:
      summary: >-
        TAS annotation from Jinquan et al. (1999). The study showed that eotaxin,
        in combination with IL-2 and IL-4, enhances expression of adhesion molecules
        (ICAM-1, CD29, CD49a, CD49b) on T lymphocytes and promotes adhesion and
        aggregation. However, the adhesion effect required prior IL-2/IL-4 stimulation
        to induce CCR3 expression on T cells and is an indirect consequence of
        chemokine signaling.
      action: KEEP_AS_NON_CORE
      reason: >-
        Cell adhesion promotion by CCL11 is context-dependent (requires IL-2/IL-4
        co-stimulation to induce CCR3 on T cells) and is a downstream consequence
        of CCR3 signaling rather than a direct adhesion function.
      supported_by:
        - reference_id: PMID:10201960
          supporting_text: "In combination with IL-2 and IL-4, eotaxin enhances the expression of adhesion molecules such as ICAM-1 and several integrins (CD29, CD49a, and CD49b) on T lymphocytes and thus promotes adhesion and aggregation of T lymphocytes."

  - term:
      id: GO:0007165
      label: signal transduction
    evidence_type: TAS
    original_reference_id: PMID:10706854
    review:
      summary: >-
        TAS annotation from Kampen et al. (2000). The study demonstrated that eotaxin
        induces signal transduction through CCR3, activating ERK2 and p38 MAP kinases.
        Signal transduction is a very broad term; more specific terms are available.
      action: ACCEPT
      reason: >-
        While very broad, signal transduction is correct for CCL11 as a signaling
        ligand that activates receptor-mediated signaling cascades. More specific
        terms (chemokine-mediated signaling pathway) are also annotated.

  - term:
      id: GO:0009314
      label: response to radiation
    evidence_type: TAS
    original_reference_id: PMID:10708591
    review:
      summary: >-
        TAS annotation from Huber et al. (2000). The paper showed that CCL11 (eotaxin)
        expression is upregulated by ionizing radiation in human dermal fibroblasts.
        This describes the regulation of CCL11 gene expression in response to radiation,
        not a function of the CCL11 protein.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        This annotation describes the induction of CCL11 gene expression by ionizing
        radiation, not a function of the CCL11 protein itself. The CCL11 protein does
        not sense or respond to radiation; rather, its expression is upregulated by
        radiation in certain cell types. This is an annotation about gene regulation
        inappropriately applied to the gene product.
      supported_by:
        - reference_id: PMID:10708591
          supporting_text: "the expression of eotaxin is upregulated upon treatment with ionizing radiation (IR) in human dermal fibroblasts"

  - term:
      id: GO:0009615
      label: response to virus
    evidence_type: TAS
    original_reference_id: PMID:9558100
    review:
      summary: >-
        TAS annotation from Rubbert et al. (1998). The paper describes CCR3 as an HIV
        coreceptor on dendritic cells. CCR3 is identified as an eotaxin receptor on
        dendritic cells that may be used for HIV entry. However, this paper does not
        demonstrate a role for CCL11 in response to virus -- rather, it shows that
        the CCL11 receptor CCR3 can be exploited by HIV for cell entry. This is an
        over-annotation.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        The cited paper describes CCR3 (the eotaxin receptor) as an HIV coreceptor
        on dendritic cells. This does not demonstrate that CCL11 protein itself
        participates in response to virus. The viral exploitation of CCR3 is a
        property of the receptor, not the chemokine ligand.
      supported_by:
        - reference_id: PMID:9558100
          supporting_text: "CCR3, the eotaxin receptor, initially identified on eosinophils, is expressed on DC and may be used as an entry coreceptor by certain dual-tropic strains."

core_functions:
  - molecular_function:
      id: GO:0008009
      label: chemokine activity
    description: >-
      CCL11 (Eotaxin-1) functions as a secreted CC chemokine that acts in the
      extracellular space as a potent and selective chemoattractant for eosinophils.
      This is its defining and canonical function. It was named "eotaxin" specifically
      for this eosinophil-selective chemotactic activity. CCL11 plays a central role
      in allergic/type-2 inflammatory responses by recruiting eosinophils to sites of
      inflammation, and is implicated in the pathogenesis of asthma, atopic dermatitis,
      eosinophilic esophagitis, and other eosinophilic inflammatory diseases.
    directly_involved_in:
      - id: GO:0048245
        label: eosinophil chemotaxis
      - id: GO:0006954
        label: inflammatory response
    locations:
      - id: GO:0005615
        label: extracellular space

  - molecular_function:
      id: GO:0031728
      label: CCR3 chemokine receptor binding
    description: >-
      CCL11 binds with high affinity to CCR3, a G-protein-coupled receptor expressed
      primarily on eosinophils, basophils, and certain other cell types. CCR3 binding
      is the molecular mechanism by which CCL11 exerts its chemotactic and signaling
      functions. Upon binding, CCR3 activates downstream signaling cascades including
      calcium mobilization, ERK2/p38 MAP kinase activation, and cytoskeletal
      rearrangement.
    directly_involved_in:
      - id: GO:0070098
        label: chemokine-mediated signaling pathway
    locations:
      - id: GO:0005615
        label: extracellular space

references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with GO terms
    findings: []
  - id: GO_REF:0000024
    title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
    findings: []
  - id: GO_REF:0000107
    title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
    findings: []
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods
    findings: []
  - id: PMID:8597956
    title: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.
    findings:
      - statement: Original cloning and functional characterization of human CCL11/eotaxin as a specific eosinophil chemoattractant.
  - id: PMID:8631813
    title: Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.
    findings:
      - statement: Identified CCR3 as the specific receptor for eotaxin/CCL11.
  - id: PMID:9712872
    title: Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.
    findings:
      - statement: Determined NMR solution structure of eotaxin showing typical chemokine fold.
      - statement: Showed monomer-dimer equilibrium under a wide range of conditions.
  - id: PMID:10072545
    title: Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    findings:
      - statement: Demonstrated eotaxin and eotaxin-2 are the most potent CCR3-acting chemokines for eosinophil shape change.
      - statement: Showed CCL11 induces cytoskeletal rearrangement and shape change in eosinophils via CCR3.
  - id: PMID:10201960
    title: Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
    findings:
      - statement: Showed eotaxin can induce T cell chemotaxis and adhesion but only after IL-2/IL-4 induction of CCR3 expression.
  - id: PMID:10415069
    title: "Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS."
    findings:
      - statement: Demonstrated CCR3 on fetal neurons responds to chemokine ligands with calcium mobilization.
  - id: PMID:10706854
    title: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases.
    findings:
      - statement: Showed eotaxin induces concentration-dependent phosphorylation of ERK2 and p38 in eosinophils.
      - statement: Demonstrated MAP kinase activation is required for eotaxin-induced degranulation and chemotaxis.
  - id: PMID:10708591
    title: Cell-type-dependent induction of eotaxin and CCR3 by ionizing radiation.
    findings:
      - statement: Showed eotaxin expression is upregulated by ionizing radiation in dermal fibroblasts.
  - id: PMID:11425309
    title: NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3.
    findings:
      - statement: Structural study of eotaxin-3 (CCL26), which shares CCR3 as receptor with CCL11.
  - id: PMID:18275857
    title: Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8.
    findings:
      - statement: Surveyed chemokines for DPP8 cleavage; CCL11 was not a novel DPP8 substrate.
  - id: PMID:19525930
    title: CCR3 is a target for age-related macular degeneration diagnosis and therapy.
    findings:
      - statement: Demonstrated CCL11/eotaxins promote endothelial cell proliferation, actin polymerization, and migration via CCR3.
      - statement: Showed CCR3 targeting inhibits choroidal neovascularization.
      - statement: Genetic ablation of Ccl11 reduced CNV in mice.
  - id: PMID:20041150
    title: Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels.
    findings:
      - statement: Measured CCL11 levels in plasma (demonstrates extracellular localization).
  - id: PMID:21314817
    title: "Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α."
    findings:
      - statement: FAP showed negligible hydrolysis of chemokines including CCL11.
  - id: PMID:23597562
    title: Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
    findings:
      - statement: IntAct interaction data for CCL11-CCR3 binding derived from this study.
  - id: PMID:28381538
    title: Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.
    findings:
      - statement: Systematic mapping of chemokine-chemokine interactions including CCL11 heteromeric interactions.
  - id: PMID:33846499
    title: Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis.
    findings:
      - statement: Demonstrated CCL11 induces migration of RA FLS and THP-1 monocytes.
      - statement: Showed CCL11 siRNA knockdown reduces FLS migration.
      - statement: CCL11 levels elevated in RA serum and synovial fluid.
  - id: PMID:9558100
    title: Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry.
    findings:
      - statement: Described CCR3 as HIV coreceptor on dendritic cells.
  - id: Reactome:R-HSA-443986
    title: Receptor ACKR2 binds most inflammatory CC chemokines
    findings: []
  - id: Reactome:R-HSA-6793978
    title: Expression of STAT6-upregulated extracellular proteins
    findings: []